id	sid	tid	token	lemma	pos
aiua-4756	1	1	stesura	stesura	PROPN
aiua-4756	1	2	seveso	seveso	PROPN
aiua-4756	1	3	archivio	archivio	PROPN
aiua-4756	1	4	italiano	italiano	X
aiua-4756	1	5	di	di	X
aiua-4756	1	6	urologia	urologia	PROPN
aiua-4756	1	7	e	e	PROPN
aiua-4756	1	8	andrologia	andrologia	NOUN
aiua-4756	1	9	2014	2014	NUM
aiua-4756	1	10	;	;	PUNCT
aiua-4756	1	11	86	86	NUM
aiua-4756	1	12	,	,	PUNCT
aiua-4756	1	13	3202	3202	NUM
aiua-4756	1	14	original	original	ADJ
aiua-4756	1	15	paper	paper	NOUN
aiua-4756	1	16	empiric	empiric	NOUN
aiua-4756	1	17	antibiotics	antibiotic	NOUN
aiua-4756	1	18	therapy	therapy	NOUN
aiua-4756	1	19	for	for	ADP
aiua-4756	1	20	mildly	mildly	ADV
aiua-4756	1	21	elevated	elevate	VERB
aiua-4756	1	22	prostate	prostate	NOUN
aiua-4756	1	23	specific	specific	ADJ
aiua-4756	1	24	antigen	antigen	NOUN
aiua-4756	1	25	:	:	PUNCT
aiua-4756	1	26	helpful	helpful	ADJ
aiua-4756	1	27	to	to	PART
aiua-4756	1	28	avoid	avoid	VERB
aiua-4756	1	29	unnecessary	unnecessary	ADJ
aiua-4756	1	30	biopsies	biopsy	NOUN
aiua-4756	1	31	?	?	PUNCT
aiua-4756	2	1	andrea	andrea	PROPN
aiua-4756	2	2	fandella	fandella	PROPN
aiua-4756	2	3	1	1	NUM
aiua-4756	2	4	,	,	PUNCT
aiua-4756	2	5	sara	sara	PROPN
aiua-4756	2	6	benvenuto	benvenuto	PROPN
aiua-4756	2	7	1	1	NUM
aiua-4756	2	8	,	,	PUNCT
aiua-4756	2	9	elisa	elisa	PROPN
aiua-4756	2	10	guidoni	guidoni	PROPN
aiua-4756	2	11	1	1	NUM
aiua-4756	2	12	,	,	PUNCT
aiua-4756	2	13	marco	marco	PROPN
aiua-4756	2	14	giampaoli	giampaoli	PROPN
aiua-4756	2	15	2	2	NUM
aiua-4756	2	16	,	,	PUNCT
aiua-4756	2	17	alessandro	alessandro	NOUN
aiua-4756	2	18	bertaccini	bertaccini	VERB
aiua-4756	2	19	2	2	NUM
aiua-4756	2	20	1	1	NUM
aiua-4756	2	21	urology	urology	NOUN
aiua-4756	2	22	,	,	PUNCT
aiua-4756	2	23	casa	casa	PROPN
aiua-4756	2	24	di	di	PROPN
aiua-4756	2	25	cura	cura	PROPN
aiua-4756	2	26	giovanni	giovanni	PROPN
aiua-4756	2	27	xxiii	xxiii	PROPN
aiua-4756	2	28	monastier	monastier	PROPN
aiua-4756	2	29	,	,	PUNCT
aiua-4756	2	30	treviso	treviso	PROPN
aiua-4756	2	31	,	,	PUNCT
aiua-4756	2	32	italy	italy	PROPN
aiua-4756	2	33	;	;	PUNCT
aiua-4756	2	34	2	2	NUM
aiua-4756	2	35	clinica	clinica	PROPN
aiua-4756	2	36	urologica	urologica	PROPN
aiua-4756	2	37	,	,	PUNCT
aiua-4756	2	38	alma	alma	NOUN
aiua-4756	2	39	mater	mater	PROPN
aiua-4756	2	40	studiorum	studiorum	PROPN
aiua-4756	2	41	,	,	PUNCT
aiua-4756	2	42	università	università	PROPN
aiua-4756	2	43	di	di	PROPN
aiua-4756	2	44	bologna	bologna	PROPN
aiua-4756	2	45	,	,	PUNCT
aiua-4756	2	46	italy	italy	PROPN
aiua-4756	2	47	.	.	PUNCT
aiua-4756	3	1	purpose	purpose	NOUN
aiua-4756	3	2	:	:	PUNCT
aiua-4756	3	3	the	the	DET
aiua-4756	3	4	management	management	NOUN
aiua-4756	3	5	of	of	ADP
aiua-4756	3	6	mildly	mildly	ADV
aiua-4756	3	7	elevated	elevated	ADJ
aiua-4756	3	8	(	(	PUNCT
aiua-4756	3	9	4.0	4.0	NUM
aiua-4756	3	10	-	-	SYM
aiua-4756	3	11	10.0	10.0	NUM
aiua-4756	3	12	ng	ng	PROPN
aiua-4756	3	13	/	/	SYM
aiua-4756	3	14	ml	ml	NOUN
aiua-4756	3	15	)	)	PUNCT
aiua-4756	3	16	prostate	prostate	NOUN
aiua-4756	3	17	specific	specific	ADJ
aiua-4756	3	18	antigen	antigen	NOUN
aiua-4756	3	19	(	(	PUNCT
aiua-4756	3	20	psa	psa	NOUN
aiua-4756	3	21	)	)	PUNCT
aiua-4756	3	22	is	be	AUX
aiua-4756	3	23	uncertain	uncertain	ADJ
aiua-4756	3	24	.	.	PUNCT
aiua-4756	4	1	immediate	immediate	ADJ
aiua-4756	4	2	prostate	prostate	NOUN
aiua-4756	4	3	biopsy	biopsy	NOUN
aiua-4756	4	4	,	,	PUNCT
aiua-4756	4	5	antibiotic	antibiotic	ADJ
aiua-4756	4	6	treatment	treatment	NOUN
aiua-4756	4	7	,	,	PUNCT
aiua-4756	4	8	or	or	CCONJ
aiua-4756	4	9	monitoring	monitor	VERB
aiua-4756	4	10	psa	psa	VERB
aiua-4756	4	11	level	level	NOUN
aiua-4756	4	12	for	for	ADP
aiua-4756	4	13	1	1	NUM
aiua-4756	4	14	-	-	SYM
aiua-4756	4	15	3	3	NUM
aiua-4756	4	16	months	month	NOUN
aiua-4756	4	17	is	be	AUX
aiua-4756	4	18	still	still	ADV
aiua-4756	4	19	in	in	ADP
aiua-4756	4	20	controversy	controversy	NOUN
aiua-4756	4	21	.	.	PUNCT
aiua-4756	5	1	materials	material	NOUN
aiua-4756	5	2	and	and	CCONJ
aiua-4756	5	3	methods	method	NOUN
aiua-4756	5	4	:	:	PUNCT
aiua-4756	5	5	we	we	PRON
aiua-4756	5	6	retrospectively	retrospectively	ADV
aiua-4756	5	7	analysed	analyse	VERB
aiua-4756	5	8	the	the	DET
aiua-4756	5	9	effect	effect	NOUN
aiua-4756	5	10	of	of	ADP
aiua-4756	5	11	empiric	empiric	ADJ
aiua-4756	5	12	antibiotics	antibiotic	NOUN
aiua-4756	5	13	on	on	ADP
aiua-4756	5	14	an	an	DET
aiua-4756	5	15	increased	increase	VERB
aiua-4756	5	16	psa	psa	NOUN
aiua-4756	5	17	in	in	ADP
aiua-4756	5	18	a	a	DET
aiua-4756	5	19	mono	mono	NOUN
aiua-4756	5	20	-	-	PUNCT
aiua-4756	5	21	institutional	institutional	ADJ
aiua-4756	5	22	study	study	NOUN
aiua-4756	5	23	.	.	PUNCT
aiua-4756	6	1	we	we	PRON
aiua-4756	6	2	analysed	analyse	VERB
aiua-4756	6	3	the	the	DET
aiua-4756	6	4	data	datum	NOUN
aiua-4756	6	5	of	of	ADP
aiua-4756	6	6	100	100	NUM
aiua-4756	6	7	patients	patient	NOUN
aiua-4756	6	8	with	with	ADP
aiua-4756	6	9	a	a	DET
aiua-4756	6	10	psa	psa	NOUN
aiua-4756	6	11	of	of	ADP
aiua-4756	6	12	4	4	NUM
aiua-4756	6	13	-	-	SYM
aiua-4756	6	14	10	10	NUM
aiua-4756	6	15	ng	ng	PROPN
aiua-4756	6	16	/	/	SYM
aiua-4756	6	17	ml	ml	NOUN
aiua-4756	6	18	and	and	CCONJ
aiua-4756	6	19	normal	normal	ADJ
aiua-4756	6	20	digital	digital	ADJ
aiua-4756	6	21	rectal	rectal	ADJ
aiua-4756	6	22	examination	examination	NOUN
aiua-4756	6	23	undergoing	undergo	VERB
aiua-4756	6	24	their	their	PRON
aiua-4756	6	25	first	first	ADJ
aiua-4756	6	26	prostate	prostate	NOUN
aiua-4756	6	27	biopsy	biopsy	NOUN
aiua-4756	6	28	.	.	PUNCT
aiua-4756	7	1	patients	patient	NOUN
aiua-4756	7	2	were	be	AUX
aiua-4756	7	3	divided	divide	VERB
aiua-4756	7	4	in	in	ADP
aiua-4756	7	5	two	two	NUM
aiua-4756	7	6	different	different	ADJ
aiua-4756	7	7	cohorts	cohort	NOUN
aiua-4756	7	8	.	.	PUNCT
aiua-4756	8	1	one	one	NUM
aiua-4756	8	2	cohort	cohort	NOUN
aiua-4756	8	3	was	be	AUX
aiua-4756	8	4	submitted	submit	VERB
aiua-4756	8	5	to	to	ADP
aiua-4756	8	6	antibiotic	antibiotic	ADJ
aiua-4756	8	7	therapy	therapy	NOUN
aiua-4756	8	8	(	(	PUNCT
aiua-4756	8	9	levoxacin	levoxacin	PROPN
aiua-4756	8	10	500	500	NUM
aiua-4756	8	11	mg	mg	NOUN
aiua-4756	8	12	daily	daily	ADV
aiua-4756	8	13	for	for	ADP
aiua-4756	8	14	20	20	NUM
aiua-4756	8	15	days	day	NOUN
aiua-4756	8	16	)	)	PUNCT
aiua-4756	8	17	and	and	CCONJ
aiua-4756	8	18	both	both	DET
aiua-4756	8	19	cohort	cohort	NOUN
aiua-4756	8	20	had	have	VERB
aiua-4756	8	21	a	a	DET
aiua-4756	8	22	re	re	NOUN
aiua-4756	8	23	-	-	NOUN
aiua-4756	8	24	dosing	dosing	ADJ
aiua-4756	8	25	of	of	ADP
aiua-4756	8	26	psa	psa	NOUN
aiua-4756	8	27	before	before	ADP
aiua-4756	8	28	the	the	DET
aiua-4756	8	29	prostate	prostate	NOUN
aiua-4756	8	30	biopsy	biopsy	NOUN
aiua-4756	8	31	.	.	PUNCT
aiua-4756	9	1	results	result	NOUN
aiua-4756	9	2	:	:	PUNCT
aiua-4756	9	3	average	average	ADJ
aiua-4756	9	4	age	age	NOUN
aiua-4756	9	5	of	of	ADP
aiua-4756	9	6	the	the	DET
aiua-4756	9	7	whole	whole	ADJ
aiua-4756	9	8	group	group	NOUN
aiua-4756	9	9	of	of	ADP
aiua-4756	9	10	patients	patient	NOUN
aiua-4756	9	11	was	be	AUX
aiua-4756	9	12	66.48	66.48	NUM
aiua-4756	9	13	±	±	NUM
aiua-4756	9	14	8.32	8.32	NUM
aiua-4756	9	15	years	year	NOUN
aiua-4756	9	16	and	and	CCONJ
aiua-4756	9	17	their	their	PRON
aiua-4756	9	18	average	average	ADJ
aiua-4756	9	19	initial	initial	ADJ
aiua-4756	9	20	psa	psa	NOUN
aiua-4756	9	21	level	level	NOUN
aiua-4756	9	22	was	be	AUX
aiua-4756	9	23	6.67	6.67	NUM
aiua-4756	9	24	±	±	NUM
aiua-4756	9	25	1.57	1.57	NUM
aiua-4756	9	26	ng	ng	PROPN
aiua-4756	9	27	/	/	SYM
aiua-4756	9	28	ml	ml	PROPN
aiua-4756	9	29	.	.	PUNCT
aiua-4756	10	1	in	in	ADP
aiua-4756	10	2	the	the	DET
aiua-4756	10	3	treated	treat	VERB
aiua-4756	10	4	group	group	NOUN
aiua-4756	10	5	(	(	PUNCT
aiua-4756	10	6	n	n	NOUN
aiua-4756	10	7	=	=	SYM
aiua-4756	10	8	49	49	NUM
aiua-4756	10	9	)	)	PUNCT
aiua-4756	10	10	29	29	NUM
aiua-4756	10	11	patients	patient	NOUN
aiua-4756	10	12	had	have	VERB
aiua-4756	10	13	a	a	DET
aiua-4756	10	14	decreasing	decrease	VERB
aiua-4756	10	15	psa	psa	NOUN
aiua-4756	10	16	value	value	NOUN
aiua-4756	10	17	from	from	ADP
aiua-4756	10	18	mean	mean	ADJ
aiua-4756	10	19	baseline	baseline	NOUN
aiua-4756	10	20	psa	psa	NOUN
aiua-4756	10	21	value	value	NOUN
aiua-4756	10	22	of	of	ADP
aiua-4756	10	23	6.6	6.6	NUM
aiua-4756	10	24	±	±	NUM
aiua-4756	10	25	1.54	1.54	NUM
aiua-4756	10	26	ng	ng	NOUN
aiua-4756	10	27	/	/	SYM
aiua-4756	10	28	ml	ml	NOUN
aiua-4756	10	29	to	to	ADP
aiua-4756	10	30	the	the	DET
aiua-4756	10	31	re	re	ADJ
aiua-4756	10	32	-	-	ADJ
aiua-4756	10	33	dosed	dose	VERB
aiua-4756	10	34	mean	mean	NOUN
aiua-4756	10	35	psa	psa	NOUN
aiua-4756	10	36	level	level	NOUN
aiua-4756	10	37	of	of	ADP
aiua-4756	10	38	5.4	5.4	NUM
aiua-4756	10	39	±	±	NUM
aiua-4756	10	40	1,61	1,61	PROPN
aiua-4756	10	41	ng	ng	PROPN
aiua-4756	10	42	/	/	SYM
aiua-4756	10	43	ml	ml	PROPN
aiua-4756	11	1	(	(	PUNCT
aiua-4756	11	2	p	p	NOUN
aiua-4756	11	3	=	=	NOUN
aiua-4756	11	4	0.7	0.7	NUM
aiua-4756	11	5	)	)	PUNCT
aiua-4756	11	6	;	;	PUNCT
aiua-4756	11	7	20	20	NUM
aiua-4756	11	8	patients	patient	NOUN
aiua-4756	11	9	did	do	AUX
aiua-4756	11	10	n’t	not	PART
aiua-4756	11	11	experience	experience	VERB
aiua-4756	11	12	a	a	DET
aiua-4756	11	13	decrease	decrease	NOUN
aiua-4756	11	14	psa	psa	NOUN
aiua-4756	11	15	value	value	NOUN
aiua-4756	11	16	,	,	PUNCT
aiua-4756	11	17	with	with	ADP
aiua-4756	11	18	a	a	DET
aiua-4756	11	19	mean	mean	ADJ
aiua-4756	11	20	psa	psa	NOUN
aiua-4756	11	21	level	level	NOUN
aiua-4756	11	22	of	of	ADP
aiua-4756	11	23	6.9	6.9	NUM
aiua-4756	11	24	±	±	NUM
aiua-4756	11	25	1.68	1.68	NUM
aiua-4756	11	26	ng	ng	PROPN
aiua-4756	11	27	/	/	SYM
aiua-4756	11	28	ml	ml	PROPN
aiua-4756	11	29	.	.	PUNCT
aiua-4756	12	1	in	in	ADP
aiua-4756	12	2	the	the	DET
aiua-4756	12	3	control	control	NOUN
aiua-4756	12	4	group	group	NOUN
aiua-4756	12	5	(	(	PUNCT
aiua-4756	12	6	n	n	NOUN
aiua-4756	12	7	=	=	SYM
aiua-4756	12	8	51	51	NUM
aiua-4756	12	9	)	)	PUNCT
aiua-4756	12	10	,	,	PUNCT
aiua-4756	12	11	30	30	NUM
aiua-4756	12	12	patients	patient	NOUN
aiua-4756	12	13	had	have	VERB
aiua-4756	12	14	a	a	DET
aiua-4756	12	15	decrease	decrease	NOUN
aiua-4756	12	16	of	of	ADP
aiua-4756	12	17	psa	psa	NOUN
aiua-4756	12	18	level	level	NOUN
aiua-4756	12	19	from	from	ADP
aiua-4756	12	20	mean	mean	ADJ
aiua-4756	12	21	baseline	baseline	NOUN
aiua-4756	12	22	psa	psa	NOUN
aiua-4756	12	23	level	level	NOUN
aiua-4756	12	24	of	of	ADP
aiua-4756	12	25	6.5	6.5	NUM
aiua-4756	12	26	±	±	NUM
aiua-4756	12	27	1,59	1,59	NUM
aiua-4756	12	28	ng	ng	PROPN
aiua-4756	12	29	/	/	SYM
aiua-4756	12	30	ml	ml	X
aiua-4756	12	31	to	to	ADP
aiua-4756	12	32	a	a	DET
aiua-4756	12	33	re	re	ADJ
aiua-4756	12	34	-	-	ADJ
aiua-4756	12	35	dosed	dose	VERB
aiua-4756	12	36	psa	psa	NOUN
aiua-4756	12	37	level	level	NOUN
aiua-4756	12	38	of	of	ADP
aiua-4756	12	39	5.5	5.5	NUM
aiua-4756	12	40	±	±	NUM
aiua-4756	12	41	1.57	1.57	NUM
aiua-4756	12	42	ng	ng	PROPN
aiua-4756	12	43	/	/	SYM
aiua-4756	12	44	ml	ml	PROPN
aiua-4756	12	45	;	;	PUNCT
aiua-4756	12	46	21	21	NUM
aiua-4756	12	47	patients	patient	NOUN
aiua-4756	12	48	did	do	AUX
aiua-4756	12	49	n’t	not	PART
aiua-4756	12	50	experience	experience	VERB
aiua-4756	12	51	a	a	DET
aiua-4756	12	52	decrease	decrease	NOUN
aiua-4756	12	53	of	of	ADP
aiua-4756	12	54	psa	psa	NOUN
aiua-4756	12	55	value	value	NOUN
aiua-4756	12	56	,	,	PUNCT
aiua-4756	12	57	with	with	ADP
aiua-4756	12	58	a	a	DET
aiua-4756	12	59	mean	mean	ADJ
aiua-4756	12	60	psa	psa	NOUN
aiua-4756	12	61	level	level	NOUN
aiua-4756	12	62	of	of	ADP
aiua-4756	12	63	6.7	6.7	NUM
aiua-4756	12	64	±	±	NUM
aiua-4756	12	65	1.71	1.71	NUM
aiua-4756	12	66	ng	ng	PROPN
aiua-4756	12	67	/	/	SYM
aiua-4756	12	68	ml	ml	PROPN
aiua-4756	12	69	.	.	PUNCT
aiua-4756	13	1	multivariate	multivariate	VERB
aiua-4756	13	2	analysis	analysis	NOUN
aiua-4756	13	3	of	of	ADP
aiua-4756	13	4	age	age	NOUN
aiua-4756	13	5	,	,	PUNCT
aiua-4756	13	6	psa	psa	VERB
aiua-4756	13	7	changes	change	NOUN
aiua-4756	13	8	,	,	PUNCT
aiua-4756	13	9	antibiotics	antibiotic	NOUN
aiua-4756	13	10	therapy	therapy	NOUN
aiua-4756	13	11	and	and	CCONJ
aiua-4756	13	12	biopsy	biopsy	NOUN
aiua-4756	13	13	results	result	NOUN
aiua-4756	13	14	(	(	PUNCT
aiua-4756	13	15	presence	presence	NOUN
aiua-4756	13	16	or	or	CCONJ
aiua-4756	13	17	absence	absence	NOUN
aiua-4756	13	18	of	of	ADP
aiua-4756	13	19	cancer	cancer	NOUN
aiua-4756	13	20	)	)	PUNCT
aiua-4756	13	21	revealed	reveal	VERB
aiua-4756	13	22	no	no	DET
aiua-4756	13	23	significant	significant	ADJ
aiua-4756	13	24	difference	difference	NOUN
aiua-4756	13	25	between	between	ADP
aiua-4756	13	26	the	the	DET
aiua-4756	13	27	two	two	NUM
aiua-4756	13	28	cohorts	cohort	NOUN
aiua-4756	13	29	.	.	PUNCT
aiua-4756	14	1	sepsis	sepsis	NOUN
aiua-4756	14	2	after	after	SCONJ
aiua-4756	14	3	biopsy	biopsy	NOUN
aiua-4756	14	4	occurred	occur	VERB
aiua-4756	14	5	in	in	ADP
aiua-4756	14	6	3	3	NUM
aiua-4756	14	7	patient	patient	NOUN
aiua-4756	14	8	in	in	ADP
aiua-4756	14	9	the	the	DET
aiua-4756	14	10	antibiotics	antibiotic	NOUN
aiua-4756	14	11	group	group	NOUN
aiua-4756	14	12	(	(	PUNCT
aiua-4756	14	13	6	6	NUM
aiua-4756	14	14	%	%	NOUN
aiua-4756	14	15	)	)	PUNCT
aiua-4756	14	16	and	and	CCONJ
aiua-4756	14	17	in	in	ADP
aiua-4756	14	18	one	one	NUM
aiua-4756	14	19	of	of	ADP
aiua-4756	14	20	the	the	DET
aiua-4756	14	21	control	control	NOUN
aiua-4756	14	22	group	group	NOUN
aiua-4756	14	23	(	(	PUNCT
aiua-4756	14	24	2	2	NUM
aiua-4756	14	25	%	%	NOUN
aiua-4756	14	26	)	)	PUNCT
aiua-4756	14	27	.	.	PUNCT
aiua-4756	15	1	conclusions	conclusion	NOUN
aiua-4756	15	2	:	:	PUNCT
aiua-4756	15	3	the	the	DET
aiua-4756	15	4	study	study	NOUN
aiua-4756	15	5	,	,	PUNCT
aiua-4756	15	6	even	even	ADV
aiua-4756	15	7	with	with	ADP
aiua-4756	15	8	some	some	DET
aiua-4756	15	9	limitations	limitation	NOUN
aiua-4756	15	10	,	,	PUNCT
aiua-4756	15	11	does	do	AUX
aiua-4756	15	12	not	not	PART
aiua-4756	15	13	seem	seem	VERB
aiua-4756	15	14	to	to	PART
aiua-4756	15	15	show	show	VERB
aiua-4756	15	16	an	an	DET
aiua-4756	15	17	advantage	advantage	NOUN
aiua-4756	15	18	due	due	ADP
aiua-4756	15	19	to	to	ADP
aiua-4756	15	20	the	the	DET
aiua-4756	15	21	administration	administration	NOUN
aiua-4756	15	22	of	of	ADP
aiua-4756	15	23	antibacterial	antibacterial	ADJ
aiua-4756	15	24	therapy	therapy	NOUN
aiua-4756	15	25	to	to	PART
aiua-4756	15	26	reduce	reduce	VERB
aiua-4756	15	27	psa	psa	NOUN
aiua-4756	15	28	values	value	NOUN
aiua-4756	15	29	before	before	ADP
aiua-4756	15	30	prostate	prostate	NOUN
aiua-4756	15	31	biopsy	biopsy	NOUN
aiua-4756	15	32	and	and	CCONJ
aiua-4756	15	33	subsequently	subsequently	ADV
aiua-4756	15	34	to	to	PART
aiua-4756	15	35	reduce	reduce	VERB
aiua-4756	15	36	unnecessary	unnecessary	ADJ
aiua-4756	15	37	prostate	prostate	NOUN
aiua-4756	15	38	biopsies	biopsy	NOUN
aiua-4756	15	39	.	.	PUNCT
aiua-4756	16	1	key	key	ADJ
aiua-4756	16	2	words	word	NOUN
aiua-4756	16	3	:	:	PUNCT
aiua-4756	16	4	psa	psa	NOUN
aiua-4756	16	5	;	;	PUNCT
aiua-4756	16	6	antibiotics	antibiotic	NOUN
aiua-4756	16	7	;	;	PUNCT
aiua-4756	16	8	biopsy	biopsy	NOUN
aiua-4756	16	9	;	;	PUNCT
aiua-4756	16	10	prostate	prostate	NOUN
aiua-4756	16	11	cancer	cancer	NOUN
aiua-4756	16	12	;	;	PUNCT
aiua-4756	16	13	fluorquinolone	fluorquinolone	NOUN
aiua-4756	16	14	.	.	PUNCT
aiua-4756	16	15	submitted	submit	VERB
aiua-4756	16	16	21	21	NUM
aiua-4756	16	17	august	august	PROPN
aiua-4756	16	18	2014	2014	NUM
aiua-4756	16	19	;	;	PUNCT
aiua-4756	16	20	accepted	accept	VERB
aiua-4756	16	21	30	30	NUM
aiua-4756	16	22	august	august	PROPN
aiua-4756	16	23	2014	2014	NUM
aiua-4756	16	24	summary	summary	NOUN
aiua-4756	16	25	no	no	DET
aiua-4756	16	26	conflict	conflict	NOUN
aiua-4756	16	27	of	of	ADP
aiua-4756	16	28	interest	interest	NOUN
aiua-4756	16	29	declared	declare	VERB
aiua-4756	16	30	.	.	PUNCT
aiua-4756	17	1	introduction	introduction	NOUN
aiua-4756	17	2	prostate	prostate	NOUN
aiua-4756	17	3	specific	specific	ADJ
aiua-4756	17	4	antigen	antigen	NOUN
aiua-4756	17	5	(	(	PUNCT
aiua-4756	17	6	psa	psa	NOUN
aiua-4756	17	7	)	)	PUNCT
aiua-4756	17	8	is	be	AUX
aiua-4756	17	9	a	a	DET
aiua-4756	17	10	serum	serum	NOUN
aiua-4756	17	11	protein	protein	NOUN
aiua-4756	17	12	secreted	secrete	VERB
aiua-4756	17	13	by	by	ADP
aiua-4756	17	14	prostate	prostate	NOUN
aiua-4756	17	15	tissue	tissue	NOUN
aiua-4756	17	16	both	both	CCONJ
aiua-4756	17	17	in	in	ADP
aiua-4756	17	18	benign	benign	ADJ
aiua-4756	17	19	and	and	CCONJ
aiua-4756	17	20	malignant	malignant	ADJ
aiua-4756	17	21	conditions	condition	NOUN
aiua-4756	17	22	.	.	PUNCT
aiua-4756	18	1	elevated	elevated	ADJ
aiua-4756	18	2	values	value	NOUN
aiua-4756	18	3	of	of	ADP
aiua-4756	18	4	serum	serum	NOUN
aiua-4756	18	5	psa	psa	NOUN
aiua-4756	18	6	are	be	AUX
aiua-4756	18	7	not	not	PART
aiua-4756	18	8	pathognomonic	pathognomonic	ADJ
aiua-4756	18	9	for	for	ADP
aiua-4756	18	10	prostate	prostate	NOUN
aiua-4756	18	11	cancer	cancer	NOUN
aiua-4756	18	12	but	but	CCONJ
aiua-4756	18	13	they	they	PRON
aiua-4756	18	14	can	can	AUX
aiua-4756	18	15	be	be	AUX
aiua-4756	18	16	found	find	VERB
aiua-4756	18	17	in	in	ADP
aiua-4756	18	18	various	various	ADJ
aiua-4756	18	19	clinical	clinical	ADJ
aiua-4756	18	20	conditions	condition	NOUN
aiua-4756	18	21	,	,	PUNCT
aiua-4756	18	22	including	include	VERB
aiua-4756	18	23	inflammation	inflammation	NOUN
aiua-4756	18	24	and	and	CCONJ
aiua-4756	18	25	infection	infection	NOUN
aiua-4756	18	26	(	(	PUNCT
aiua-4756	18	27	1	1	NUM
aiua-4756	18	28	)	)	PUNCT
aiua-4756	18	29	.	.	PUNCT
aiua-4756	19	1	in	in	ADP
aiua-4756	19	2	men	man	NOUN
aiua-4756	19	3	with	with	ADP
aiua-4756	19	4	an	an	DET
aiua-4756	19	5	increasing	increase	VERB
aiua-4756	19	6	psa	psa	NOUN
aiua-4756	19	7	without	without	ADP
aiua-4756	19	8	clinical	clinical	ADJ
aiua-4756	19	9	evidence	evidence	NOUN
aiua-4756	19	10	of	of	ADP
aiua-4756	19	11	infection	infection	NOUN
aiua-4756	19	12	,	,	PUNCT
aiua-4756	19	13	a	a	DET
aiua-4756	19	14	common	common	ADJ
aiua-4756	19	15	clinical	clinical	ADJ
aiua-4756	19	16	approach	approach	NOUN
aiua-4756	19	17	is	be	AUX
aiua-4756	19	18	to	to	PART
aiua-4756	19	19	empirically	empirically	ADV
aiua-4756	19	20	prescribe	prescribe	VERB
aiua-4756	19	21	antibiotics	antibiotic	NOUN
aiua-4756	19	22	and	and	CCONJ
aiua-4756	19	23	subsequently	subsequently	ADV
aiua-4756	19	24	re	re	VERB
aiua-4756	19	25	-	-	VERB
aiua-4756	19	26	dose	dose	VERB
aiua-4756	19	27	the	the	DET
aiua-4756	19	28	psa	psa	NOUN
aiua-4756	19	29	.	.	PUNCT
aiua-4756	20	1	until	until	ADP
aiua-4756	20	2	today	today	NOUN
aiua-4756	20	3	,	,	PUNCT
aiua-4756	20	4	several	several	ADJ
aiua-4756	20	5	researchers	researcher	NOUN
aiua-4756	20	6	have	have	AUX
aiua-4756	20	7	examined	examine	VERB
aiua-4756	20	8	the	the	DET
aiua-4756	20	9	impact	impact	NOUN
aiua-4756	20	10	of	of	ADP
aiua-4756	20	11	empiric	empiric	ADJ
aiua-4756	20	12	antibiotics	antibiotic	NOUN
aiua-4756	20	13	therapy	therapy	NOUN
aiua-4756	20	14	in	in	ADP
aiua-4756	20	15	patients	patient	NOUN
aiua-4756	20	16	with	with	ADP
aiua-4756	20	17	an	an	DET
aiua-4756	20	18	increased	increase	VERB
aiua-4756	20	19	psa	psa	NOUN
aiua-4756	20	20	,	,	PUNCT
aiua-4756	20	21	in	in	ADP
aiua-4756	20	22	order	order	NOUN
aiua-4756	20	23	to	to	PART
aiua-4756	20	24	find	find	VERB
aiua-4756	20	25	a	a	DET
aiua-4756	20	26	balanced	balanced	ADJ
aiua-4756	20	27	costs	cost	NOUN
aiua-4756	20	28	/	/	SYM
aiua-4756	20	29	effective	effective	ADJ
aiua-4756	20	30	therapy	therapy	NOUN
aiua-4756	20	31	to	to	PART
aiua-4756	20	32	avoid	avoid	VERB
aiua-4756	20	33	unnecessary	unnecessary	ADJ
aiua-4756	20	34	prostate	prostate	NOUN
aiua-4756	20	35	biopsies	biopsy	NOUN
aiua-4756	20	36	and	and	CCONJ
aiua-4756	20	37	to	to	PART
aiua-4756	20	38	decrease	decrease	VERB
aiua-4756	20	39	patient	patient	ADJ
aiua-4756	20	40	discomfort	discomfort	NOUN
aiua-4756	20	41	and	and	CCONJ
aiua-4756	20	42	morbidity	morbidity	NOUN
aiua-4756	20	43	from	from	ADP
aiua-4756	20	44	biopsies	biopsy	NOUN
aiua-4756	20	45	(	(	PUNCT
aiua-4756	20	46	2	2	NUM
aiua-4756	20	47	,	,	PUNCT
aiua-4756	20	48	3	3	NUM
aiua-4756	20	49	)	)	PUNCT
aiua-4756	20	50	.	.	PUNCT
aiua-4756	21	1	the	the	DET
aiua-4756	21	2	common	common	ADJ
aiua-4756	21	3	rational	rational	NOUN
aiua-4756	21	4	is	be	AUX
aiua-4756	21	5	to	to	PART
aiua-4756	21	6	treat	treat	VERB
aiua-4756	21	7	a	a	DET
aiua-4756	21	8	subclinical	subclinical	ADJ
aiua-4756	21	9	prostate	prostate	NOUN
aiua-4756	21	10	infection	infection	NOUN
aiua-4756	21	11	,	,	PUNCT
aiua-4756	21	12	having	have	VERB
aiua-4756	21	13	as	as	SCONJ
aiua-4756	21	14	result	result	VERB
aiua-4756	21	15	a	a	DET
aiua-4756	21	16	lower	low	ADJ
aiua-4756	21	17	serum	serum	NOUN
aiua-4756	21	18	psa	psa	NOUN
aiua-4756	21	19	.	.	PUNCT
aiua-4756	22	1	this	this	PRON
aiua-4756	22	2	might	might	AUX
aiua-4756	22	3	lead	lead	VERB
aiua-4756	22	4	to	to	PART
aiua-4756	22	5	lower	lower	VERB
aiua-4756	22	6	the	the	DET
aiua-4756	22	7	rate	rate	NOUN
aiua-4756	22	8	of	of	ADP
aiua-4756	22	9	unnecessary	unnecessary	ADJ
aiua-4756	22	10	prostate	prostate	NOUN
aiua-4756	22	11	biopsies	biopsy	NOUN
aiua-4756	22	12	,	,	PUNCT
aiua-4756	22	13	since	since	SCONJ
aiua-4756	22	14	unproven	unproven	ADJ
aiua-4756	22	15	sub	sub	NOUN
aiua-4756	22	16	clinical	clinical	ADJ
aiua-4756	22	17	prostatitis	prostatitis	NOUN
aiua-4756	22	18	are	be	AUX
aiua-4756	22	19	responsible	responsible	ADJ
aiua-4756	22	20	for	for	ADP
aiua-4756	22	21	the	the	DET
aiua-4756	22	22	majority	majority	NOUN
aiua-4756	22	23	of	of	ADP
aiua-4756	22	24	false	false	ADJ
aiua-4756	22	25	positive	positive	ADJ
aiua-4756	22	26	psa	psa	NOUN
aiua-4756	22	27	elevations	elevation	NOUN
aiua-4756	22	28	(	(	PUNCT
aiua-4756	22	29	4	4	NUM
aiua-4756	22	30	-	-	SYM
aiua-4756	22	31	6	6	NUM
aiua-4756	22	32	)	)	PUNCT
aiua-4756	22	33	.	.	PUNCT
aiua-4756	23	1	however	however	ADV
aiua-4756	23	2	,	,	PUNCT
aiua-4756	23	3	most	most	ADJ
aiua-4756	23	4	of	of	ADP
aiua-4756	23	5	the	the	DET
aiua-4756	23	6	studies	study	NOUN
aiua-4756	23	7	available	available	ADJ
aiua-4756	23	8	in	in	ADP
aiua-4756	23	9	the	the	DET
aiua-4756	23	10	literature	literature	NOUN
aiua-4756	23	11	are	be	AUX
aiua-4756	23	12	limited	limit	VERB
aiua-4756	23	13	because	because	SCONJ
aiua-4756	23	14	they	they	PRON
aiua-4756	23	15	lack	lack	VERB
aiua-4756	23	16	a	a	DET
aiua-4756	23	17	control	control	NOUN
aiua-4756	23	18	arm	arm	NOUN
aiua-4756	23	19	,	,	PUNCT
aiua-4756	23	20	so	so	SCONJ
aiua-4756	23	21	it	it	PRON
aiua-4756	23	22	is	be	AUX
aiua-4756	23	23	unclear	unclear	ADJ
aiua-4756	23	24	if	if	SCONJ
aiua-4756	23	25	the	the	DET
aiua-4756	23	26	observed	observed	ADJ
aiua-4756	23	27	psa	psa	NOUN
aiua-4756	23	28	changes	change	NOUN
aiua-4756	23	29	were	be	AUX
aiua-4756	23	30	secondary	secondary	ADJ
aiua-4756	23	31	to	to	ADP
aiua-4756	23	32	natural	natural	ADJ
aiua-4756	23	33	variations	variation	NOUN
aiua-4756	23	34	or	or	CCONJ
aiua-4756	23	35	to	to	ADP
aiua-4756	23	36	the	the	DET
aiua-4756	23	37	effect	effect	NOUN
aiua-4756	23	38	of	of	ADP
aiua-4756	23	39	the	the	DET
aiua-4756	23	40	antibacterial	antibacterial	ADJ
aiua-4756	23	41	therapies	therapy	NOUN
aiua-4756	23	42	(	(	PUNCT
aiua-4756	23	43	7	7	NUM
aiua-4756	23	44	)	)	PUNCT
aiua-4756	23	45	.	.	PUNCT
aiua-4756	24	1	the	the	DET
aiua-4756	24	2	potential	potential	ADJ
aiua-4756	24	3	disadvantages	disadvantage	NOUN
aiua-4756	24	4	of	of	ADP
aiua-4756	24	5	an	an	DET
aiua-4756	24	6	empiric	empiric	ADJ
aiua-4756	24	7	antibiotic	antibiotic	ADJ
aiua-4756	24	8	approach	approach	NOUN
aiua-4756	24	9	include	include	VERB
aiua-4756	24	10	unnecessary	unnecessary	ADJ
aiua-4756	24	11	expenses	expense	NOUN
aiua-4756	24	12	,	,	PUNCT
aiua-4756	24	13	side	side	NOUN
aiua-4756	24	14	effects	effect	NOUN
aiua-4756	24	15	and	and	CCONJ
aiua-4756	24	16	possible	possible	ADJ
aiua-4756	24	17	adverse	adverse	ADJ
aiua-4756	24	18	reactions	reaction	NOUN
aiua-4756	24	19	related	relate	VERB
aiua-4756	24	20	to	to	ADP
aiua-4756	24	21	the	the	DET
aiua-4756	24	22	drug	drug	NOUN
aiua-4756	24	23	intake	intake	NOUN
aiua-4756	24	24	and	and	CCONJ
aiua-4756	24	25	an	an	DET
aiua-4756	24	26	increase	increase	NOUN
aiua-4756	24	27	in	in	ADP
aiua-4756	24	28	multidrug	multidrug	NOUN
aiua-4756	24	29	resistant	resistant	ADJ
aiua-4756	24	30	organisms	organism	NOUN
aiua-4756	24	31	(	(	PUNCT
aiua-4756	24	32	8)	8)	NUM
aiua-4756	24	33	.	.	PUNCT
aiua-4756	25	1	our	our	PRON
aiua-4756	25	2	goal	goal	NOUN
aiua-4756	25	3	was	be	AUX
aiua-4756	25	4	to	to	PART
aiua-4756	25	5	investigate	investigate	VERB
aiua-4756	25	6	if	if	SCONJ
aiua-4756	25	7	an	an	DET
aiua-4756	25	8	antibiotic	antibiotic	ADJ
aiua-4756	25	9	therapy	therapy	NOUN
aiua-4756	25	10	in	in	ADP
aiua-4756	25	11	patients	patient	NOUN
aiua-4756	25	12	eligible	eligible	ADJ
aiua-4756	25	13	for	for	ADP
aiua-4756	25	14	prostate	prostate	NOUN
aiua-4756	25	15	biopsies	biopsy	NOUN
aiua-4756	25	16	might	might	AUX
aiua-4756	25	17	be	be	AUX
aiua-4756	25	18	effective	effective	ADJ
aiua-4756	25	19	in	in	ADP
aiua-4756	25	20	order	order	NOUN
aiua-4756	25	21	to	to	PART
aiua-4756	25	22	avoid	avoid	VERB
aiua-4756	25	23	unnecessary	unnecessary	ADJ
aiua-4756	25	24	biopsies	biopsy	NOUN
aiua-4756	25	25	so	so	ADV
aiua-4756	25	26	reducing	reduce	VERB
aiua-4756	25	27	false	false	ADJ
aiua-4756	25	28	positive	positive	ADJ
aiua-4756	25	29	psa	psa	NOUN
aiua-4756	25	30	elevation	elevation	NOUN
aiua-4756	25	31	.	.	PUNCT
aiua-4756	26	1	materials	material	NOUN
aiua-4756	26	2	and	and	CCONJ
aiua-4756	26	3	methods	method	NOUN
aiua-4756	26	4	we	we	PRON
aiua-4756	26	5	conducted	conduct	VERB
aiua-4756	26	6	a	a	DET
aiua-4756	26	7	retrospective	retrospective	ADJ
aiua-4756	26	8	mono	mono	NOUN
aiua-4756	26	9	-	-	PUNCT
aiua-4756	26	10	institutional	institutional	ADJ
aiua-4756	26	11	study	study	NOUN
aiua-4756	26	12	(	(	PUNCT
aiua-4756	26	13	casa	casa	PROPN
aiua-4756	26	14	di	di	PROPN
aiua-4756	26	15	cura	cura	PROPN
aiua-4756	26	16	giovanni	giovanni	PROPN
aiua-4756	26	17	xxiii	xxiii	PROPN
aiua-4756	26	18	monastier	monastier	PROPN
aiua-4756	26	19	,	,	PUNCT
aiua-4756	26	20	treviso	treviso	PROPN
aiua-4756	26	21	,	,	PUNCT
aiua-4756	26	22	italy	italy	PROPN
aiua-4756	26	23	)	)	PUNCT
aiua-4756	26	24	.	.	PUNCT
aiua-4756	27	1	we	we	PRON
aiua-4756	27	2	analysed	analyse	VERB
aiua-4756	27	3	the	the	DET
aiua-4756	27	4	data	datum	NOUN
aiua-4756	27	5	of	of	ADP
aiua-4756	27	6	two	two	NUM
aiua-4756	27	7	different	different	ADJ
aiua-4756	27	8	cohort	cohort	NOUN
aiua-4756	27	9	of	of	ADP
aiua-4756	27	10	patients	patient	NOUN
aiua-4756	27	11	,	,	PUNCT
aiua-4756	27	12	all	all	PRON
aiua-4756	27	13	submitted	submit	VERB
aiua-4756	27	14	to	to	ADP
aiua-4756	27	15	their	their	PRON
aiua-4756	27	16	first	first	ADJ
aiua-4756	27	17	prostate	prostate	NOUN
aiua-4756	27	18	biopsy	biopsy	NOUN
aiua-4756	27	19	set	set	VERB
aiua-4756	27	20	in	in	ADP
aiua-4756	27	21	the	the	DET
aiua-4756	27	22	last	last	ADJ
aiua-4756	27	23	3	3	NUM
aiua-4756	27	24	years	year	NOUN
aiua-4756	27	25	in	in	ADP
aiua-4756	27	26	our	our	PRON
aiua-4756	27	27	institution	institution	NOUN
aiua-4756	27	28	.	.	PUNCT
aiua-4756	28	1	the	the	DET
aiua-4756	28	2	first	first	ADJ
aiua-4756	28	3	cohort	cohort	NOUN
aiua-4756	28	4	(	(	PUNCT
aiua-4756	28	5	n	n	NOUN
aiua-4756	28	6	=	=	SYM
aiua-4756	28	7	49	49	NUM
aiua-4756	28	8	)	)	PUNCT
aiua-4756	28	9	included	include	VERB
aiua-4756	28	10	patients	patient	NOUN
aiua-4756	28	11	treated	treat	VERB
aiua-4756	28	12	with	with	ADP
aiua-4756	28	13	an	an	DET
aiua-4756	28	14	antibiotic	antibiotic	ADJ
aiua-4756	28	15	therapy	therapy	NOUN
aiua-4756	28	16	(	(	PUNCT
aiua-4756	28	17	levofloxacin	levofloxacin	NOUN
aiua-4756	28	18	500	500	NUM
aiua-4756	28	19	mg	mg	NOUN
aiua-4756	28	20	daily	daily	ADV
aiua-4756	28	21	)	)	PUNCT
aiua-4756	28	22	for	for	ADP
aiua-4756	28	23	at	at	ADV
aiua-4756	28	24	least	least	ADV
aiua-4756	28	25	20	20	NUM
aiua-4756	28	26	days	day	NOUN
aiua-4756	28	27	and	and	CCONJ
aiua-4756	28	28	then	then	ADV
aiua-4756	28	29	doi	doi	PROPN
aiua-4756	28	30	:	:	PUNCT
aiua-4756	28	31	10.4081	10.4081	NUM
aiua-4756	28	32	/	/	SYM
aiua-4756	28	33	aiua.2014.3.202	aiua.2014.3.202	PROPN
aiua-4756	28	34	fandella_stesura	fandella_stesura	NOUN
aiua-4756	28	35	seveso	seveso	VERB
aiua-4756	28	36	08/10/14	08/10/14	PROPN
aiua-4756	28	37	12:12	12:12	NUM
aiua-4756	28	38	pagina	pagina	NOUN
aiua-4756	28	39	202	202	NUM
aiua-4756	28	40	203archivio	203archivio	PROPN
aiua-4756	28	41	italiano	italiano	NOUN
aiua-4756	28	42	di	di	X
aiua-4756	28	43	urologia	urologia	PROPN
aiua-4756	28	44	e	e	PROPN
aiua-4756	28	45	andrologia	andrologia	NOUN
aiua-4756	28	46	2014	2014	NUM
aiua-4756	28	47	;	;	PUNCT
aiua-4756	28	48	86	86	NUM
aiua-4756	28	49	,	,	PUNCT
aiua-4756	28	50	3	3	NUM
aiua-4756	28	51	empiric	empiric	ADJ
aiua-4756	28	52	antibiotics	antibiotic	NOUN
aiua-4756	28	53	therapy	therapy	NOUN
aiua-4756	28	54	for	for	ADP
aiua-4756	28	55	mildly	mildly	ADV
aiua-4756	28	56	elevated	elevate	VERB
aiua-4756	28	57	prostate	prostate	NOUN
aiua-4756	28	58	specific	specific	ADJ
aiua-4756	28	59	antigen	antigen	NOUN
aiua-4756	28	60	:	:	PUNCT
aiua-4756	28	61	helpful	helpful	ADJ
aiua-4756	28	62	to	to	PART
aiua-4756	28	63	avoid	avoid	VERB
aiua-4756	28	64	unnecessary	unnecessary	ADJ
aiua-4756	28	65	biopsies	biopsy	NOUN
aiua-4756	28	66	?	?	PUNCT
aiua-4756	29	1	submitted	submit	VERB
aiua-4756	29	2	to	to	PART
aiua-4756	29	3	psa	psa	VERB
aiua-4756	29	4	re	re	VERB
aiua-4756	29	5	-	-	VERB
aiua-4756	29	6	dosing	dose	VERB
aiua-4756	29	7	prior	prior	ADV
aiua-4756	29	8	to	to	ADP
aiua-4756	29	9	the	the	DET
aiua-4756	29	10	prostate	prostate	NOUN
aiua-4756	29	11	biopsy	biopsy	NOUN
aiua-4756	29	12	.	.	PUNCT
aiua-4756	30	1	otherwise	otherwise	ADV
aiua-4756	30	2	,	,	PUNCT
aiua-4756	30	3	the	the	DET
aiua-4756	30	4	second	second	ADJ
aiua-4756	30	5	cohort	cohort	NOUN
aiua-4756	30	6	(	(	PUNCT
aiua-4756	30	7	n	n	NOUN
aiua-4756	30	8	=	=	SYM
aiua-4756	30	9	51	51	NUM
aiua-4756	30	10	)	)	PUNCT
aiua-4756	30	11	included	include	VERB
aiua-4756	30	12	patients	patient	NOUN
aiua-4756	30	13	with	with	ADP
aiua-4756	30	14	no	no	DET
aiua-4756	30	15	antibiotic	antibiotic	ADJ
aiua-4756	30	16	therapy	therapy	NOUN
aiua-4756	30	17	but	but	CCONJ
aiua-4756	30	18	with	with	ADP
aiua-4756	30	19	psa	psa	NOUN
aiua-4756	30	20	re	re	VERB
aiua-4756	30	21	-	-	VERB
aiua-4756	30	22	dosing	dose	VERB
aiua-4756	30	23	before	before	ADP
aiua-4756	30	24	prostate	prostate	NOUN
aiua-4756	30	25	biopsy	biopsy	NOUN
aiua-4756	30	26	.	.	PUNCT
aiua-4756	31	1	both	both	DET
aiua-4756	31	2	cohort	cohort	NOUN
aiua-4756	31	3	presented	present	VERB
aiua-4756	31	4	psa	psa	NOUN
aiua-4756	31	5	levels	level	NOUN
aiua-4756	31	6	between	between	ADP
aiua-4756	31	7	4.0	4.0	NUM
aiua-4756	31	8	-	-	SYM
aiua-4756	31	9	10	10	NUM
aiua-4756	31	10	ng	ng	PROPN
aiua-4756	31	11	/	/	SYM
aiua-4756	31	12	ml	ml	PROPN
aiua-4756	31	13	,	,	PUNCT
aiua-4756	31	14	no	no	DET
aiua-4756	31	15	prior	prior	ADJ
aiua-4756	31	16	diagnosis	diagnosis	NOUN
aiua-4756	31	17	of	of	ADP
aiua-4756	31	18	prostate	prostate	NOUN
aiua-4756	31	19	cancer	cancer	NOUN
aiua-4756	31	20	or	or	CCONJ
aiua-4756	31	21	pre	pre	ADJ
aiua-4756	31	22	-	-	ADJ
aiua-4756	31	23	neoplastic	neoplastic	ADJ
aiua-4756	31	24	lesions	lesion	NOUN
aiua-4756	31	25	(	(	PUNCT
aiua-4756	31	26	hgpin	hgpin	NOUN
aiua-4756	31	27	/	/	PUNCT
aiua-4756	31	28	asap	asap	PROPN
aiua-4756	31	29	)	)	PUNCT
aiua-4756	31	30	,	,	PUNCT
aiua-4756	31	31	a	a	DET
aiua-4756	31	32	negative	negative	ADJ
aiua-4756	31	33	digital	digital	ADJ
aiua-4756	31	34	rectal	rectal	ADJ
aiua-4756	31	35	examination	examination	NOUN
aiua-4756	31	36	(	(	PUNCT
aiua-4756	31	37	dre	dre	PROPN
aiua-4756	31	38	)	)	PUNCT
aiua-4756	31	39	and	and	CCONJ
aiua-4756	31	40	no	no	DET
aiua-4756	31	41	clinical	clinical	ADJ
aiua-4756	31	42	or	or	CCONJ
aiua-4756	31	43	laboratory	laboratory	NOUN
aiua-4756	31	44	signs	sign	NOUN
aiua-4756	31	45	of	of	ADP
aiua-4756	31	46	urinary	urinary	ADJ
aiua-4756	31	47	infections	infection	NOUN
aiua-4756	31	48	(	(	PUNCT
aiua-4756	31	49	negative	negative	ADJ
aiua-4756	31	50	urine	urine	NOUN
aiua-4756	31	51	sediment	sediment	NOUN
aiua-4756	31	52	and	and	CCONJ
aiua-4756	31	53	negative	negative	ADJ
aiua-4756	31	54	urine	urine	NOUN
aiua-4756	31	55	culture	culture	NOUN
aiua-4756	31	56	)	)	PUNCT
aiua-4756	31	57	.	.	PUNCT
aiua-4756	32	1	the	the	DET
aiua-4756	32	2	analysed	analyse	VERB
aiua-4756	32	3	data	datum	NOUN
aiua-4756	32	4	included	include	VERB
aiua-4756	32	5	patient	patient	NOUN
aiua-4756	32	6	’s	’s	PART
aiua-4756	32	7	age	age	NOUN
aiua-4756	32	8	and	and	CCONJ
aiua-4756	32	9	history	history	NOUN
aiua-4756	32	10	.	.	PUNCT
aiua-4756	33	1	cases	case	NOUN
aiua-4756	33	2	with	with	ADP
aiua-4756	33	3	reported	report	VERB
aiua-4756	33	4	events	event	NOUN
aiua-4756	33	5	that	that	PRON
aiua-4756	33	6	could	could	AUX
aiua-4756	33	7	have	have	AUX
aiua-4756	33	8	falsely	falsely	ADV
aiua-4756	33	9	elevated	elevate	VERB
aiua-4756	33	10	the	the	DET
aiua-4756	33	11	psa	psa	NOUN
aiua-4756	33	12	result	result	NOUN
aiua-4756	33	13	(	(	PUNCT
aiua-4756	33	14	e.g.	e.g.	ADV
aiua-4756	33	15	urinary	urinary	ADJ
aiua-4756	33	16	tract	tract	NOUN
aiua-4756	33	17	infection	infection	NOUN
aiua-4756	33	18	,	,	PUNCT
aiua-4756	33	19	urinary	urinary	ADJ
aiua-4756	33	20	retention	retention	NOUN
aiua-4756	33	21	,	,	PUNCT
aiua-4756	33	22	urinary	urinary	ADJ
aiua-4756	33	23	catheterization	catheterization	NOUN
aiua-4756	33	24	…	…	PUNCT
aiua-4756	33	25	)	)	PUNCT
aiua-4756	33	26	were	be	AUX
aiua-4756	33	27	excluded	exclude	VERB
aiua-4756	33	28	from	from	ADP
aiua-4756	33	29	the	the	DET
aiua-4756	33	30	study	study	NOUN
aiua-4756	33	31	.	.	PUNCT
aiua-4756	34	1	all	all	DET
aiua-4756	34	2	the	the	DET
aiua-4756	34	3	specimens	specimen	NOUN
aiua-4756	34	4	were	be	AUX
aiua-4756	34	5	analysed	analyse	VERB
aiua-4756	34	6	in	in	ADP
aiua-4756	34	7	our	our	PRON
aiua-4756	34	8	laboratory	laboratory	NOUN
aiua-4756	34	9	(	(	PUNCT
aiua-4756	34	10	using	use	VERB
aiua-4756	34	11	beckam	beckam	ADJ
aiua-4756	34	12	coulter	coulter	PROPN
aiua-4756	34	13	access	access	PROPN
aiua-4756	34	14	ii	ii	PROPN
aiua-4756	34	15	immunoassay	immunoassay	PROPN
aiua-4756	34	16	system	system	NOUN
aiua-4756	34	17	psa	psa	NOUN
aiua-4756	34	18	)	)	PUNCT
aiua-4756	34	19	.	.	PUNCT
aiua-4756	35	1	analysis	analysis	NOUN
aiua-4756	35	2	of	of	ADP
aiua-4756	35	3	data	datum	NOUN
aiua-4756	35	4	[	[	X
aiua-4756	35	5	age	age	NOUN
aiua-4756	35	6	,	,	PUNCT
aiua-4756	35	7	psa	psa	VERB
aiua-4756	35	8	changes	change	NOUN
aiua-4756	35	9	,	,	PUNCT
aiua-4756	35	10	antibiotic	antibiotic	ADJ
aiua-4756	35	11	therapy	therapy	NOUN
aiua-4756	35	12	,	,	PUNCT
aiua-4756	35	13	biopsy	biopsy	NOUN
aiua-4756	35	14	result	result	NOUN
aiua-4756	35	15	(	(	PUNCT
aiua-4756	35	16	presence	presence	NOUN
aiua-4756	35	17	of	of	ADP
aiua-4756	35	18	cancer	cancer	NOUN
aiua-4756	35	19	)	)	PUNCT
aiua-4756	35	20	]	]	PUNCT
aiua-4756	35	21	was	be	AUX
aiua-4756	35	22	carried	carry	VERB
aiua-4756	35	23	out	out	ADP
aiua-4756	35	24	using	use	VERB
aiua-4756	35	25	spss	spss	ADJ
aiua-4756	35	26	statistical	statistical	ADJ
aiua-4756	35	27	analysis	analysis	NOUN
aiua-4756	35	28	software	software	NOUN
aiua-4756	35	29	(	(	PUNCT
aiua-4756	35	30	ibm	ibm	PROPN
aiua-4756	35	31	spss	spss	PROPN
aiua-4756	35	32	statistics	statistic	NOUN
aiua-4756	35	33	21	21	NUM
aiua-4756	35	34	)	)	PUNCT
aiua-4756	35	35	.	.	PUNCT
aiua-4756	36	1	data	datum	NOUN
aiua-4756	36	2	of	of	ADP
aiua-4756	36	3	the	the	DET
aiua-4756	36	4	second	second	ADJ
aiua-4756	36	5	cohort	cohort	NOUN
aiua-4756	36	6	(	(	PUNCT
aiua-4756	36	7	n	n	NOUN
aiua-4756	36	8	=	=	SYM
aiua-4756	36	9	51	51	NUM
aiua-4756	36	10	)	)	PUNCT
aiua-4756	36	11	was	be	AUX
aiua-4756	36	12	used	use	VERB
aiua-4756	36	13	as	as	ADP
aiua-4756	36	14	control	control	NOUN
aiua-4756	36	15	group	group	NOUN
aiua-4756	36	16	.	.	PUNCT
aiua-4756	37	1	kolmogorov	kolmogorov	PROPN
aiua-4756	37	2	-	-	PUNCT
aiua-4756	37	3	smirnov	smirnov	PROPN
aiua-4756	37	4	test	test	NOUN
aiua-4756	37	5	(	(	PUNCT
aiua-4756	37	6	cut	cut	VERB
aiua-4756	37	7	off	off	ADP
aiua-4756	37	8	at	at	ADP
aiua-4756	37	9	p	p	NOUN
aiua-4756	37	10	<	<	X
aiua-4756	37	11	0.01	0.01	NUM
aiua-4756	37	12	)	)	PUNCT
aiua-4756	37	13	was	be	AUX
aiua-4756	37	14	performed	perform	VERB
aiua-4756	37	15	.	.	PUNCT
aiua-4756	38	1	continuous	continuous	ADJ
aiua-4756	38	2	variables	variable	NOUN
aiua-4756	38	3	were	be	AUX
aiua-4756	38	4	described	describe	VERB
aiua-4756	38	5	using	use	VERB
aiua-4756	38	6	mean	mean	PROPN
aiua-4756	38	7	±	±	NUM
aiua-4756	38	8	standard	standard	ADJ
aiua-4756	38	9	deviation	deviation	NOUN
aiua-4756	38	10	.	.	PUNCT
aiua-4756	39	1	categorical	categorical	ADJ
aiua-4756	39	2	variables	variable	NOUN
aiua-4756	39	3	were	be	AUX
aiua-4756	39	4	described	describe	VERB
aiua-4756	39	5	using	use	VERB
aiua-4756	39	6	frequency	frequency	NOUN
aiua-4756	39	7	distributions	distribution	NOUN
aiua-4756	39	8	(	(	PUNCT
aiua-4756	39	9	frequency	frequency	NOUN
aiua-4756	39	10	%	%	NOUN
aiua-4756	39	11	)	)	PUNCT
aiua-4756	39	12	.	.	PUNCT
aiua-4756	40	1	psa	psa	VERB
aiua-4756	40	2	values	value	NOUN
aiua-4756	40	3	prior	prior	ADV
aiua-4756	40	4	to	to	ADP
aiua-4756	40	5	and	and	CCONJ
aiua-4756	40	6	following	follow	VERB
aiua-4756	40	7	antibiotic	antibiotic	ADJ
aiua-4756	40	8	therapy	therapy	NOUN
aiua-4756	40	9	were	be	AUX
aiua-4756	40	10	compared	compare	VERB
aiua-4756	40	11	using	use	VERB
aiua-4756	40	12	the	the	DET
aiua-4756	40	13	student’s	student’s	NOUN
aiua-4756	40	14	-	-	PUNCT
aiua-4756	40	15	t	t	NOUN
aiua-4756	40	16	-	-	PUNCT
aiua-4756	40	17	test	test	NOUN
aiua-4756	40	18	for	for	ADP
aiua-4756	40	19	independent	independent	ADJ
aiua-4756	40	20	samples	sample	NOUN
aiua-4756	40	21	and	and	CCONJ
aiua-4756	40	22	a	a	DET
aiua-4756	40	23	multivariate	multivariate	NOUN
aiua-4756	40	24	logistic	logistic	ADJ
aiua-4756	40	25	regression	regression	NOUN
aiua-4756	40	26	analysis	analysis	NOUN
aiua-4756	40	27	was	be	AUX
aiua-4756	40	28	performed	perform	VERB
aiua-4756	40	29	.	.	PUNCT
aiua-4756	41	1	all	all	DET
aiua-4756	41	2	tests	test	NOUN
aiua-4756	41	3	were	be	AUX
aiua-4756	41	4	two	two	NUM
aiua-4756	41	5	-	-	PUNCT
aiua-4756	41	6	sided	sided	ADJ
aiua-4756	41	7	and	and	CCONJ
aiua-4756	41	8	considered	consider	VERB
aiua-4756	41	9	significant	significant	ADJ
aiua-4756	41	10	at	at	ADP
aiua-4756	41	11	p	p	X
aiua-4756	41	12	<	<	X
aiua-4756	41	13	0.05	0.05	NUM
aiua-4756	41	14	.	.	PUNCT
aiua-4756	42	1	all	all	DET
aiua-4756	42	2	the	the	DET
aiua-4756	42	3	patients	patient	NOUN
aiua-4756	42	4	underwent	undergo	VERB
aiua-4756	42	5	to	to	ADP
aiua-4756	42	6	a	a	DET
aiua-4756	42	7	12	12	NUM
aiua-4756	42	8	-	-	PUNCT
aiua-4756	42	9	core	core	NOUN
aiua-4756	42	10	prostate	prostate	NOUN
aiua-4756	42	11	biopsy	biopsy	NOUN
aiua-4756	42	12	according	accord	VERB
aiua-4756	42	13	to	to	ADP
aiua-4756	42	14	our	our	PRON
aiua-4756	42	15	standard	standard	ADJ
aiua-4756	42	16	biopsy	biopsy	NOUN
aiua-4756	42	17	procedure	procedure	NOUN
aiua-4756	42	18	(	(	PUNCT
aiua-4756	42	19	presti	presti	NOUN
aiua-4756	42	20	procedure	procedure	NOUN
aiua-4756	42	21	)	)	PUNCT
aiua-4756	42	22	(	(	PUNCT
aiua-4756	42	23	9	9	NUM
aiua-4756	42	24	)	)	PUNCT
aiua-4756	42	25	.	.	PUNCT
aiua-4756	43	1	results	result	VERB
aiua-4756	43	2	average	average	ADJ
aiua-4756	43	3	age	age	NOUN
aiua-4756	43	4	of	of	ADP
aiua-4756	43	5	the	the	DET
aiua-4756	43	6	whole	whole	ADJ
aiua-4756	43	7	group	group	NOUN
aiua-4756	43	8	of	of	ADP
aiua-4756	43	9	patients	patient	NOUN
aiua-4756	43	10	(	(	PUNCT
aiua-4756	43	11	first	first	ADJ
aiua-4756	43	12	and	and	CCONJ
aiua-4756	43	13	second	second	ADJ
aiua-4756	43	14	cohort	cohort	NOUN
aiua-4756	43	15	)	)	PUNCT
aiua-4756	43	16	was	be	AUX
aiua-4756	43	17	66.48	66.48	NUM
aiua-4756	43	18	±	±	NUM
aiua-4756	43	19	8.32	8.32	NUM
aiua-4756	43	20	years	year	NOUN
aiua-4756	43	21	and	and	CCONJ
aiua-4756	43	22	average	average	ADJ
aiua-4756	43	23	initial	initial	ADJ
aiua-4756	43	24	psa	psa	NOUN
aiua-4756	43	25	level	level	NOUN
aiua-4756	43	26	was	be	AUX
aiua-4756	43	27	6.67	6.67	NUM
aiua-4756	43	28	±	±	NUM
aiua-4756	43	29	1.57	1.57	NUM
aiua-4756	43	30	ng	ng	PROPN
aiua-4756	43	31	/	/	SYM
aiua-4756	43	32	ml	ml	NOUN
aiua-4756	43	33	with	with	ADP
aiua-4756	43	34	no	no	DET
aiua-4756	43	35	significant	significant	ADJ
aiua-4756	43	36	difference	difference	NOUN
aiua-4756	43	37	between	between	ADP
aiua-4756	43	38	first	first	ADJ
aiua-4756	43	39	and	and	CCONJ
aiua-4756	43	40	second	second	ADJ
aiua-4756	43	41	cohort	cohort	NOUN
aiua-4756	43	42	.	.	PUNCT
aiua-4756	44	1	in	in	ADP
aiua-4756	44	2	the	the	DET
aiua-4756	44	3	treated	treat	VERB
aiua-4756	44	4	cohort	cohort	NOUN
aiua-4756	44	5	(	(	PUNCT
aiua-4756	44	6	n	n	NOUN
aiua-4756	44	7	=	=	SYM
aiua-4756	44	8	49	49	NUM
aiua-4756	44	9	)	)	PUNCT
aiua-4756	44	10	29	29	NUM
aiua-4756	44	11	patients	patient	NOUN
aiua-4756	44	12	showed	show	VERB
aiua-4756	44	13	a	a	DET
aiua-4756	44	14	decrease	decrease	NOUN
aiua-4756	44	15	of	of	ADP
aiua-4756	44	16	psa	psa	NOUN
aiua-4756	44	17	values	value	NOUN
aiua-4756	44	18	from	from	ADP
aiua-4756	44	19	mean	mean	ADJ
aiua-4756	44	20	baseline	baseline	ADJ
aiua-4756	44	21	psa	psa	NOUN
aiua-4756	44	22	of	of	ADP
aiua-4756	44	23	6.6	6.6	NUM
aiua-4756	44	24	±	±	NUM
aiua-4756	44	25	1,54	1,54	NUM
aiua-4756	44	26	ng	ng	PROPN
aiua-4756	44	27	/	/	SYM
aiua-4756	44	28	ml	ml	PUNCT
aiua-4756	44	29	to	to	ADP
aiua-4756	44	30	a	a	DET
aiua-4756	44	31	mean	mean	NOUN
aiua-4756	44	32	re	re	VERB
aiua-4756	44	33	-	-	ADJ
aiua-4756	44	34	dosed	dose	VERB
aiua-4756	44	35	psa	psa	NOUN
aiua-4756	44	36	of	of	ADP
aiua-4756	44	37	5.4	5.4	NUM
aiua-4756	44	38	±	±	NUM
aiua-4756	44	39	1,61	1,61	PROPN
aiua-4756	44	40	ng	ng	PROPN
aiua-4756	44	41	/	/	SYM
aiua-4756	44	42	ml	ml	PROPN
aiua-4756	44	43	(	(	PUNCT
aiua-4756	44	44	p	p	NOUN
aiua-4756	44	45	=	=	NOUN
aiua-4756	44	46	0.7	0.7	NUM
aiua-4756	44	47	)	)	PUNCT
aiua-4756	44	48	,	,	PUNCT
aiua-4756	44	49	while	while	SCONJ
aiua-4756	44	50	20	20	NUM
aiua-4756	44	51	patients	patient	NOUN
aiua-4756	44	52	did	do	AUX
aiua-4756	44	53	not	not	PART
aiua-4756	44	54	experience	experience	VERB
aiua-4756	44	55	a	a	DET
aiua-4756	44	56	lowering	lowering	NOUN
aiua-4756	44	57	of	of	ADP
aiua-4756	44	58	psa	psa	NOUN
aiua-4756	44	59	value	value	NOUN
aiua-4756	44	60	,	,	PUNCT
aiua-4756	44	61	with	with	ADP
aiua-4756	44	62	a	a	DET
aiua-4756	44	63	mean	mean	ADJ
aiua-4756	44	64	psa	psa	NOUN
aiua-4756	44	65	level	level	NOUN
aiua-4756	44	66	of	of	ADP
aiua-4756	44	67	6.9	6.9	NUM
aiua-4756	44	68	±	±	NUM
aiua-4756	44	69	1.68	1.68	NUM
aiua-4756	44	70	ng	ng	PROPN
aiua-4756	44	71	/	/	SYM
aiua-4756	44	72	ml	ml	PROPN
aiua-4756	44	73	.	.	PUNCT
aiua-4756	45	1	in	in	ADP
aiua-4756	45	2	the	the	DET
aiua-4756	45	3	sub	sub	NOUN
aiua-4756	45	4	-	-	NOUN
aiua-4756	45	5	group	group	NOUN
aiua-4756	45	6	with	with	ADP
aiua-4756	45	7	decreasing	decrease	VERB
aiua-4756	45	8	psa	psa	NOUN
aiua-4756	45	9	levels	level	NOUN
aiua-4756	45	10	(	(	PUNCT
aiua-4756	45	11	n	n	NOUN
aiua-4756	45	12	=	=	SYM
aiua-4756	45	13	29	29	NUM
aiua-4756	45	14	,	,	PUNCT
aiua-4756	45	15	59	59	NUM
aiua-4756	45	16	%	%	NOUN
aiua-4756	45	17	of	of	ADP
aiua-4756	45	18	first	first	ADJ
aiua-4756	45	19	cohort	cohort	NOUN
aiua-4756	45	20	)	)	PUNCT
aiua-4756	45	21	6	6	NUM
aiua-4756	45	22	patients	patient	NOUN
aiua-4756	45	23	turned	turn	VERB
aiua-4756	45	24	out	out	ADP
aiua-4756	45	25	to	to	PART
aiua-4756	45	26	have	have	VERB
aiua-4756	45	27	prostate	prostate	NOUN
aiua-4756	45	28	cancer	cancer	NOUN
aiua-4756	45	29	(	(	PUNCT
aiua-4756	45	30	21	21	NUM
aiua-4756	45	31	%	%	NOUN
aiua-4756	45	32	)	)	PUNCT
aiua-4756	45	33	,	,	PUNCT
aiua-4756	45	34	5	5	NUM
aiua-4756	45	35	chronic	chronic	ADJ
aiua-4756	45	36	inflammation	inflammation	NOUN
aiua-4756	45	37	(	(	PUNCT
aiua-4756	45	38	17	17	NUM
aiua-4756	45	39	%	%	NOUN
aiua-4756	45	40	)	)	PUNCT
aiua-4756	45	41	and	and	CCONJ
aiua-4756	45	42	18	18	NUM
aiua-4756	45	43	benign	benign	ADJ
aiua-4756	45	44	prostatic	prostatic	ADJ
aiua-4756	45	45	hyperplasia	hyperplasia	NOUN
aiua-4756	45	46	(	(	PUNCT
aiua-4756	45	47	bph	bph	NOUN
aiua-4756	45	48	)	)	PUNCT
aiua-4756	45	49	(	(	PUNCT
aiua-4756	45	50	62	62	NUM
aiua-4756	45	51	%	%	NOUN
aiua-4756	45	52	)	)	PUNCT
aiua-4756	45	53	.	.	PUNCT
aiua-4756	46	1	in	in	ADP
aiua-4756	46	2	the	the	DET
aiua-4756	46	3	sub	sub	NOUN
aiua-4756	46	4	-	-	NOUN
aiua-4756	46	5	group	group	NOUN
aiua-4756	46	6	with	with	ADP
aiua-4756	46	7	no	no	DET
aiua-4756	46	8	decrease	decrease	NOUN
aiua-4756	46	9	of	of	ADP
aiua-4756	46	10	psa	psa	NOUN
aiua-4756	46	11	levels	level	NOUN
aiua-4756	46	12	(	(	PUNCT
aiua-4756	46	13	n	n	NOUN
aiua-4756	46	14	=	=	SYM
aiua-4756	46	15	20	20	NUM
aiua-4756	46	16	,	,	PUNCT
aiua-4756	46	17	41	41	NUM
aiua-4756	46	18	%	%	NOUN
aiua-4756	46	19	of	of	ADP
aiua-4756	46	20	first	first	ADJ
aiua-4756	46	21	cohort	cohort	NOUN
aiua-4756	46	22	)	)	PUNCT
aiua-4756	46	23	4	4	NUM
aiua-4756	46	24	patients	patient	NOUN
aiua-4756	46	25	demonstrated	demonstrate	VERB
aiua-4756	46	26	to	to	PART
aiua-4756	46	27	have	have	VERB
aiua-4756	46	28	prostate	prostate	NOUN
aiua-4756	46	29	cancer	cancer	NOUN
aiua-4756	46	30	(	(	PUNCT
aiua-4756	46	31	20	20	NUM
aiua-4756	46	32	%	%	NOUN
aiua-4756	46	33	)	)	PUNCT
aiua-4756	46	34	,	,	PUNCT
aiua-4756	46	35	8	8	NUM
aiua-4756	46	36	chronic	chronic	ADJ
aiua-4756	46	37	inflammation	inflammation	NOUN
aiua-4756	46	38	(	(	PUNCT
aiua-4756	46	39	40	40	NUM
aiua-4756	46	40	%	%	NOUN
aiua-4756	46	41	)	)	PUNCT
aiua-4756	46	42	and	and	CCONJ
aiua-4756	46	43	8	8	NUM
aiua-4756	46	44	bph	bph	NOUN
aiua-4756	46	45	(	(	PUNCT
aiua-4756	46	46	40	40	NUM
aiua-4756	46	47	%	%	NOUN
aiua-4756	46	48	)	)	PUNCT
aiua-4756	46	49	.	.	PUNCT
aiua-4756	47	1	in	in	ADP
aiua-4756	47	2	the	the	DET
aiua-4756	47	3	control	control	NOUN
aiua-4756	47	4	group	group	NOUN
aiua-4756	47	5	(	(	PUNCT
aiua-4756	47	6	n	n	NOUN
aiua-4756	47	7	=	=	SYM
aiua-4756	47	8	51	51	NUM
aiua-4756	47	9	)	)	PUNCT
aiua-4756	47	10	,	,	PUNCT
aiua-4756	47	11	30	30	NUM
aiua-4756	47	12	patients	patient	NOUN
aiua-4756	47	13	showed	show	VERB
aiua-4756	47	14	a	a	DET
aiua-4756	47	15	decrease	decrease	NOUN
aiua-4756	47	16	of	of	ADP
aiua-4756	47	17	psa	psa	NOUN
aiua-4756	47	18	values	value	NOUN
aiua-4756	47	19	from	from	ADP
aiua-4756	47	20	a	a	DET
aiua-4756	47	21	mean	mean	ADJ
aiua-4756	47	22	baseline	baseline	NOUN
aiua-4756	47	23	psa	psa	NOUN
aiua-4756	47	24	of	of	ADP
aiua-4756	47	25	6.5	6.5	NUM
aiua-4756	47	26	±	±	NUM
aiua-4756	47	27	1,59	1,59	NUM
aiua-4756	47	28	ng	ng	PROPN
aiua-4756	47	29	/	/	SYM
aiua-4756	47	30	ml	ml	X
aiua-4756	47	31	to	to	ADP
aiua-4756	47	32	a	a	DET
aiua-4756	47	33	mean	mean	NOUN
aiua-4756	47	34	redosed	redose	VERB
aiua-4756	47	35	psa	psa	NOUN
aiua-4756	47	36	of	of	ADP
aiua-4756	47	37	5.5	5.5	NUM
aiua-4756	47	38	±	±	NUM
aiua-4756	47	39	1,57	1,57	NUM
aiua-4756	47	40	ng	ng	PROPN
aiua-4756	47	41	/	/	SYM
aiua-4756	47	42	ml	ml	PROPN
aiua-4756	47	43	,	,	PUNCT
aiua-4756	47	44	while	while	SCONJ
aiua-4756	47	45	21	21	NUM
aiua-4756	47	46	patients	patient	NOUN
aiua-4756	47	47	did	do	AUX
aiua-4756	47	48	not	not	PART
aiua-4756	47	49	experience	experience	VERB
aiua-4756	47	50	a	a	DET
aiua-4756	47	51	lowering	lowering	NOUN
aiua-4756	47	52	of	of	ADP
aiua-4756	47	53	psa	psa	NOUN
aiua-4756	47	54	value	value	NOUN
aiua-4756	47	55	,	,	PUNCT
aiua-4756	47	56	with	with	ADP
aiua-4756	47	57	a	a	DET
aiua-4756	47	58	mean	mean	ADJ
aiua-4756	47	59	psa	psa	NOUN
aiua-4756	47	60	level	level	NOUN
aiua-4756	47	61	of	of	ADP
aiua-4756	47	62	6.7	6.7	NUM
aiua-4756	47	63	±	±	NUM
aiua-4756	47	64	1.71	1.71	NUM
aiua-4756	47	65	ng	ng	PROPN
aiua-4756	47	66	/	/	SYM
aiua-4756	47	67	ml	ml	PROPN
aiua-4756	47	68	.	.	PUNCT
aiua-4756	48	1	in	in	ADP
aiua-4756	48	2	the	the	DET
aiua-4756	48	3	sub	sub	NOUN
aiua-4756	48	4	-	-	NOUN
aiua-4756	48	5	group	group	NOUN
aiua-4756	48	6	with	with	ADP
aiua-4756	48	7	decreasing	decrease	VERB
aiua-4756	48	8	psa	psa	NOUN
aiua-4756	48	9	level	level	NOUN
aiua-4756	48	10	(	(	PUNCT
aiua-4756	48	11	n	n	NOUN
aiua-4756	48	12	=	=	SYM
aiua-4756	48	13	30	30	NUM
aiua-4756	48	14	,	,	PUNCT
aiua-4756	48	15	59	59	NUM
aiua-4756	48	16	%	%	NOUN
aiua-4756	48	17	of	of	ADP
aiua-4756	48	18	second	second	ADJ
aiua-4756	48	19	cohort	cohort	NOUN
aiua-4756	48	20	)	)	PUNCT
aiua-4756	48	21	7	7	NUM
aiua-4756	48	22	patients	patient	NOUN
aiua-4756	48	23	turned	turn	VERB
aiua-4756	48	24	out	out	ADP
aiua-4756	48	25	to	to	PART
aiua-4756	48	26	have	have	VERB
aiua-4756	48	27	prostate	prostate	NOUN
aiua-4756	48	28	cancer	cancer	NOUN
aiua-4756	48	29	(	(	PUNCT
aiua-4756	48	30	23	23	NUM
aiua-4756	48	31	%	%	NOUN
aiua-4756	48	32	)	)	PUNCT
aiua-4756	48	33	,	,	PUNCT
aiua-4756	48	34	5	5	NUM
aiua-4756	48	35	chronic	chronic	ADJ
aiua-4756	48	36	inflammation	inflammation	NOUN
aiua-4756	48	37	(	(	PUNCT
aiua-4756	48	38	17	17	NUM
aiua-4756	48	39	%	%	NOUN
aiua-4756	48	40	)	)	PUNCT
aiua-4756	48	41	and	and	CCONJ
aiua-4756	48	42	18	18	NUM
aiua-4756	48	43	bph	bph	NOUN
aiua-4756	48	44	(	(	PUNCT
aiua-4756	48	45	60	60	NUM
aiua-4756	48	46	%	%	NOUN
aiua-4756	48	47	)	)	PUNCT
aiua-4756	48	48	.	.	PUNCT
aiua-4756	49	1	in	in	ADP
aiua-4756	49	2	the	the	DET
aiua-4756	49	3	sub	sub	NOUN
aiua-4756	49	4	-	-	NOUN
aiua-4756	49	5	group	group	NOUN
aiua-4756	49	6	with	with	ADP
aiua-4756	49	7	no	no	DET
aiua-4756	49	8	decrease	decrease	NOUN
aiua-4756	49	9	of	of	ADP
aiua-4756	49	10	psa	psa	NOUN
aiua-4756	49	11	levels	level	NOUN
aiua-4756	49	12	(	(	PUNCT
aiua-4756	49	13	n	n	NOUN
aiua-4756	49	14	=	=	SYM
aiua-4756	49	15	21	21	NUM
aiua-4756	49	16	,	,	PUNCT
aiua-4756	49	17	41	41	NUM
aiua-4756	49	18	%	%	NOUN
aiua-4756	49	19	of	of	ADP
aiua-4756	49	20	second	second	ADJ
aiua-4756	49	21	cohort	cohort	NOUN
aiua-4756	49	22	)	)	PUNCT
aiua-4756	49	23	6	6	NUM
aiua-4756	49	24	patients	patient	NOUN
aiua-4756	49	25	demonstrated	demonstrate	VERB
aiua-4756	49	26	to	to	PART
aiua-4756	49	27	have	have	VERB
aiua-4756	49	28	prostate	prostate	NOUN
aiua-4756	49	29	cancer	cancer	NOUN
aiua-4756	49	30	(	(	PUNCT
aiua-4756	49	31	29	29	NUM
aiua-4756	49	32	%	%	NOUN
aiua-4756	49	33	)	)	PUNCT
aiua-4756	49	34	,	,	PUNCT
aiua-4756	49	35	3	3	NUM
aiua-4756	49	36	chronic	chronic	ADJ
aiua-4756	49	37	inflammation	inflammation	NOUN
aiua-4756	49	38	(	(	PUNCT
aiua-4756	49	39	14	14	NUM
aiua-4756	49	40	%	%	NOUN
aiua-4756	49	41	)	)	PUNCT
aiua-4756	49	42	and	and	CCONJ
aiua-4756	49	43	12	12	NUM
aiua-4756	49	44	bph	bph	NOUN
aiua-4756	49	45	(	(	PUNCT
aiua-4756	49	46	57	57	NUM
aiua-4756	49	47	%	%	NOUN
aiua-4756	49	48	)	)	PUNCT
aiua-4756	49	49	.	.	PUNCT
aiua-4756	50	1	the	the	DET
aiua-4756	50	2	difference	difference	NOUN
aiua-4756	50	3	in	in	ADP
aiua-4756	50	4	psa	psa	NOUN
aiua-4756	50	5	changes	change	NOUN
aiua-4756	50	6	between	between	ADP
aiua-4756	50	7	the	the	DET
aiua-4756	50	8	two	two	NUM
aiua-4756	50	9	cohort	cohort	NOUN
aiua-4756	50	10	was	be	AUX
aiua-4756	50	11	not	not	PART
aiua-4756	50	12	statistically	statistically	ADV
aiua-4756	50	13	significant	significant	ADJ
aiua-4756	50	14	(	(	PUNCT
aiua-4756	50	15	p	p	X
aiua-4756	50	16	=	=	NOUN
aiua-4756	50	17	0.3	0.3	NUM
aiua-4756	50	18	)	)	PUNCT
aiua-4756	50	19	.	.	PUNCT
aiua-4756	51	1	furthermore	furthermore	ADV
aiua-4756	51	2	there	there	PRON
aiua-4756	51	3	were	be	VERB
aiua-4756	51	4	n’t	not	PART
aiua-4756	51	5	any	any	DET
aiua-4756	51	6	statistically	statistically	ADV
aiua-4756	51	7	significant	significant	ADJ
aiua-4756	51	8	differences	difference	NOUN
aiua-4756	51	9	between	between	ADP
aiua-4756	51	10	the	the	DET
aiua-4756	51	11	two	two	NUM
aiua-4756	51	12	sub	sub	NOUN
aiua-4756	51	13	-	-	NOUN
aiua-4756	51	14	groups	group	NOUN
aiua-4756	51	15	in	in	ADP
aiua-4756	51	16	each	each	DET
aiua-4756	51	17	cohort	cohort	NOUN
aiua-4756	51	18	for	for	ADP
aiua-4756	51	19	cancer	cancer	NOUN
aiua-4756	51	20	detection	detection	NOUN
aiua-4756	51	21	(	(	PUNCT
aiua-4756	51	22	p	p	X
aiua-4756	51	23	>	>	X
aiua-4756	51	24	0.5	0.5	NUM
aiua-4756	51	25	)	)	PUNCT
aiua-4756	51	26	multivariate	multivariate	NOUN
aiua-4756	51	27	analysis	analysis	NOUN
aiua-4756	51	28	of	of	ADP
aiua-4756	51	29	age	age	NOUN
aiua-4756	51	30	,	,	PUNCT
aiua-4756	51	31	psa	psa	VERB
aiua-4756	51	32	changes	change	NOUN
aiua-4756	51	33	,	,	PUNCT
aiua-4756	51	34	antibiotics	antibiotic	NOUN
aiua-4756	51	35	therapy	therapy	NOUN
aiua-4756	51	36	and	and	CCONJ
aiua-4756	51	37	biopsy	biopsy	NOUN
aiua-4756	51	38	results	result	NOUN
aiua-4756	51	39	(	(	PUNCT
aiua-4756	51	40	presence	presence	NOUN
aiua-4756	51	41	or	or	CCONJ
aiua-4756	51	42	absence	absence	NOUN
aiua-4756	51	43	of	of	ADP
aiua-4756	51	44	cancer	cancer	NOUN
aiua-4756	51	45	)	)	PUNCT
aiua-4756	51	46	revealed	reveal	VERB
aiua-4756	51	47	no	no	DET
aiua-4756	51	48	significant	significant	ADJ
aiua-4756	51	49	difference	difference	NOUN
aiua-4756	51	50	between	between	ADP
aiua-4756	51	51	the	the	DET
aiua-4756	51	52	two	two	NUM
aiua-4756	51	53	cohorts	cohort	NOUN
aiua-4756	51	54	(	(	PUNCT
aiua-4756	51	55	p	p	NOUN
aiua-4756	51	56	value	value	NOUN
aiua-4756	51	57	>	>	X
aiua-4756	51	58	0.05	0.05	NUM
aiua-4756	51	59	in	in	ADP
aiua-4756	51	60	all	all	DET
aiua-4756	51	61	categories	category	NOUN
aiua-4756	51	62	)	)	PUNCT
aiua-4756	51	63	.	.	PUNCT
aiua-4756	52	1	table	table	NOUN
aiua-4756	52	2	1	1	NUM
aiua-4756	52	3	shows	show	VERB
aiua-4756	52	4	the	the	DET
aiua-4756	52	5	distribution	distribution	NOUN
aiua-4756	52	6	of	of	ADP
aiua-4756	52	7	diagnoses	diagnosis	NOUN
aiua-4756	52	8	and	and	CCONJ
aiua-4756	52	9	performance	performance	NOUN
aiua-4756	52	10	of	of	ADP
aiua-4756	52	11	biopsies	biopsy	NOUN
aiua-4756	52	12	for	for	ADP
aiua-4756	52	13	each	each	DET
aiua-4756	52	14	subgroup	subgroup	NOUN
aiua-4756	52	15	.	.	PUNCT
aiua-4756	53	1	prostate	prostate	NOUN
aiua-4756	53	2	cancer	cancer	NOUN
aiua-4756	53	3	detection	detection	NOUN
aiua-4756	53	4	rates	rate	NOUN
aiua-4756	53	5	were	be	AUX
aiua-4756	53	6	not	not	PART
aiua-4756	53	7	significantly	significantly	ADV
aiua-4756	53	8	associated	associate	VERB
aiua-4756	53	9	with	with	ADP
aiua-4756	53	10	the	the	DET
aiua-4756	53	11	changes	change	NOUN
aiua-4756	53	12	in	in	ADP
aiua-4756	53	13	psa	psa	NOUN
aiua-4756	53	14	(	(	PUNCT
aiua-4756	53	15	either	either	CCONJ
aiua-4756	53	16	decreasing	decrease	VERB
aiua-4756	53	17	or	or	CCONJ
aiua-4756	53	18	increasing	increase	VERB
aiua-4756	53	19	)	)	PUNCT
aiua-4756	53	20	.	.	PUNCT
aiua-4756	54	1	sepsis	sepsis	NOUN
aiua-4756	54	2	after	after	SCONJ
aiua-4756	54	3	biopsy	biopsy	NOUN
aiua-4756	54	4	occurred	occur	VERB
aiua-4756	54	5	in	in	ADP
aiua-4756	54	6	3	3	NUM
aiua-4756	54	7	patient	patient	NOUN
aiua-4756	54	8	in	in	ADP
aiua-4756	54	9	the	the	DET
aiua-4756	54	10	antibiotics	antibiotic	NOUN
aiua-4756	54	11	group	group	NOUN
aiua-4756	54	12	(	(	PUNCT
aiua-4756	54	13	6	6	NUM
aiua-4756	54	14	%	%	NOUN
aiua-4756	54	15	)	)	PUNCT
aiua-4756	54	16	and	and	CCONJ
aiua-4756	54	17	in	in	ADP
aiua-4756	54	18	1	1	NUM
aiua-4756	54	19	of	of	ADP
aiua-4756	54	20	control	control	NOUN
aiua-4756	54	21	group	group	NOUN
aiua-4756	54	22	(	(	PUNCT
aiua-4756	54	23	2	2	NUM
aiua-4756	54	24	%	%	NOUN
aiua-4756	54	25	)	)	PUNCT
aiua-4756	54	26	.	.	PUNCT
aiua-4756	55	1	discussion	discussion	NOUN
aiua-4756	55	2	in	in	ADP
aiua-4756	55	3	chronic	chronic	ADJ
aiua-4756	55	4	prostatitis	prostatitis	NOUN
aiua-4756	55	5	,	,	PUNCT
aiua-4756	55	6	it	it	PRON
aiua-4756	55	7	has	have	AUX
aiua-4756	55	8	been	be	AUX
aiua-4756	55	9	shown	show	VERB
aiua-4756	55	10	that	that	SCONJ
aiua-4756	55	11	total	total	ADJ
aiua-4756	55	12	psa	psa	NOUN
aiua-4756	55	13	and	and	CCONJ
aiua-4756	55	14	free	free	ADJ
aiua-4756	55	15	psa	psa	NOUN
aiua-4756	55	16	are	be	AUX
aiua-4756	55	17	all	all	PRON
aiua-4756	55	18	significantly	significantly	ADV
aiua-4756	55	19	higher	high	ADJ
aiua-4756	55	20	in	in	ADP
aiua-4756	55	21	patients	patient	NOUN
aiua-4756	55	22	with	with	ADP
aiua-4756	55	23	infection	infection	NOUN
aiua-4756	55	24	.	.	PUNCT
aiua-4756	56	1	a	a	DET
aiua-4756	56	2	course	course	NOUN
aiua-4756	56	3	of	of	ADP
aiua-4756	56	4	fluoroquinolone	fluoroquinolone	NOUN
aiua-4756	56	5	therapy	therapy	NOUN
aiua-4756	56	6	in	in	ADP
aiua-4756	56	7	patients	patient	NOUN
aiua-4756	56	8	with	with	ADP
aiua-4756	56	9	chronic	chronic	ADJ
aiua-4756	56	10	bacterial	bacterial	ADJ
aiua-4756	56	11	prostatitis	prostatitis	NOUN
aiua-4756	56	12	resulted	result	VERB
aiua-4756	56	13	in	in	ADP
aiua-4756	56	14	a	a	DET
aiua-4756	56	15	median	median	ADJ
aiua-4756	56	16	psa	psa	NOUN
aiua-4756	56	17	decrease	decrease	NOUN
aiua-4756	56	18	from	from	ADP
aiua-4756	56	19	8.3	8.3	NUM
aiua-4756	56	20	to	to	ADP
aiua-4756	56	21	5.3	5.3	NUM
aiua-4756	56	22	ng	ng	NOUN
aiua-4756	56	23	/	/	SYM
aiua-4756	56	24	ml	ml	PROPN
aiua-4756	56	25	(	(	PUNCT
aiua-4756	56	26	10	10	NUM
aiua-4756	56	27	)	)	PUNCT
aiua-4756	56	28	.	.	PUNCT
aiua-4756	57	1	on	on	ADP
aiua-4756	57	2	the	the	DET
aiua-4756	57	3	other	other	ADJ
aiua-4756	57	4	hand	hand	NOUN
aiua-4756	57	5	,	,	PUNCT
aiua-4756	57	6	habermacher	habermacher	ADV
aiua-4756	57	7	et	et	PROPN
aiua-4756	57	8	al	al	PROPN
aiua-4756	57	9	.	.	PUNCT
aiua-4756	58	1	(	(	PUNCT
aiua-4756	58	2	11	11	NUM
aiua-4756	58	3	)	)	PUNCT
aiua-4756	58	4	demonstrated	demonstrate	VERB
aiua-4756	58	5	that	that	SCONJ
aiua-4756	58	6	most	most	ADJ
aiua-4756	58	7	cases	case	NOUN
aiua-4756	58	8	of	of	ADP
aiua-4756	58	9	asymptomatic	asymptomatic	ADJ
aiua-4756	58	10	prostatitis	prostatitis	NOUN
aiua-4756	58	11	are	be	AUX
aiua-4756	58	12	not	not	PART
aiua-4756	58	13	caused	cause	VERB
aiua-4756	58	14	by	by	ADP
aiua-4756	58	15	bacteria	bacteria	NOUN
aiua-4756	58	16	,	,	PUNCT
aiua-4756	58	17	thus	thus	ADV
aiua-4756	58	18	eliminating	eliminate	VERB
aiua-4756	58	19	the	the	DET
aiua-4756	58	20	rationale	rationale	NOUN
aiua-4756	58	21	for	for	ADP
aiua-4756	58	22	antibacterial	antibacterial	ADJ
aiua-4756	58	23	therapy	therapy	NOUN
aiua-4756	58	24	.	.	PUNCT
aiua-4756	59	1	in	in	ADP
aiua-4756	59	2	the	the	DET
aiua-4756	59	3	study	study	NOUN
aiua-4756	59	4	of	of	ADP
aiua-4756	59	5	kaygisiz	kaygisiz	PROPN
aiua-4756	59	6	et	et	PROPN
aiua-4756	59	7	al	al	PROPN
aiua-4756	59	8	.	.	PROPN
aiua-4756	60	1	(	(	PUNCT
aiua-4756	60	2	5	5	NUM
aiua-4756	60	3	)	)	PUNCT
aiua-4756	60	4	,	,	PUNCT
aiua-4756	60	5	antibiotics	antibiotic	NOUN
aiua-4756	60	6	were	be	AUX
aiua-4756	60	7	administered	administer	VERB
aiua-4756	60	8	to	to	ADP
aiua-4756	60	9	48	48	NUM
aiua-4756	60	10	patients	patient	NOUN
aiua-4756	60	11	who	who	PRON
aiua-4756	60	12	underwent	undergo	VERB
aiua-4756	60	13	to	to	ADP
aiua-4756	60	14	prostate	prostate	NOUN
aiua-4756	60	15	biopsies	biopsy	NOUN
aiua-4756	60	16	.	.	PUNCT
aiua-4756	61	1	the	the	DET
aiua-4756	61	2	psa	psa	NOUN
aiua-4756	61	3	levels	level	NOUN
aiua-4756	61	4	decreased	decrease	VERB
aiua-4756	61	5	below	below	ADP
aiua-4756	61	6	4	4	NUM
aiua-4756	61	7	ng	ng	NOUN
aiua-4756	61	8	/	/	SYM
aiua-4756	61	9	ml	ml	NOUN
aiua-4756	61	10	in	in	ADP
aiua-4756	61	11	18	18	NUM
aiua-4756	61	12	(	(	PUNCT
aiua-4756	61	13	37	37	NUM
aiua-4756	61	14	%	%	NOUN
aiua-4756	61	15	)	)	PUNCT
aiua-4756	61	16	of	of	ADP
aiua-4756	61	17	them	they	PRON
aiua-4756	61	18	and	and	CCONJ
aiua-4756	61	19	the	the	DET
aiua-4756	61	20	biopsies	biopsy	NOUN
aiua-4756	61	21	of	of	ADP
aiua-4756	61	22	these	these	DET
aiua-4756	61	23	men	man	NOUN
aiua-4756	61	24	were	be	AUX
aiua-4756	61	25	negative	negative	ADJ
aiua-4756	61	26	for	for	ADP
aiua-4756	61	27	malignancies	malignancy	NOUN
aiua-4756	61	28	.	.	PUNCT
aiua-4756	62	1	in	in	ADP
aiua-4756	62	2	the	the	DET
aiua-4756	62	3	subgroup	subgroup	NOUN
aiua-4756	62	4	of	of	ADP
aiua-4756	62	5	other	other	ADJ
aiua-4756	62	6	30	30	NUM
aiua-4756	62	7	men	man	NOUN
aiua-4756	62	8	prostate	prostate	NOUN
aiua-4756	62	9	cancer	cancer	NOUN
aiua-4756	62	10	was	be	AUX
aiua-4756	62	11	found	find	VERB
aiua-4756	62	12	in	in	ADP
aiua-4756	62	13	10.8	10.8	NUM
aiua-4756	62	14	%	%	NOUN
aiua-4756	62	15	.	.	PUNCT
aiua-4756	63	1	the	the	DET
aiua-4756	63	2	authors	author	NOUN
aiua-4756	63	3	suggested	suggest	VERB
aiua-4756	63	4	a	a	DET
aiua-4756	63	5	long	long	ADJ
aiua-4756	63	6	course	course	NOUN
aiua-4756	63	7	of	of	ADP
aiua-4756	63	8	antibiotic	antibiotic	ADJ
aiua-4756	63	9	treatment	treatment	NOUN
aiua-4756	63	10	(	(	PUNCT
aiua-4756	63	11	at	at	ADP
aiua-4756	63	12	least	least	ADV
aiua-4756	63	13	3	3	NUM
aiua-4756	63	14	weeks	week	NOUN
aiua-4756	63	15	)	)	PUNCT
aiua-4756	63	16	,	,	PUNCT
aiua-4756	63	17	regardless	regardless	ADV
aiua-4756	63	18	of	of	ADP
aiua-4756	63	19	inflammation	inflammation	NOUN
aiua-4756	63	20	findings	finding	NOUN
aiua-4756	63	21	,	,	PUNCT
aiua-4756	63	22	when	when	SCONJ
aiua-4756	63	23	psa	psa	NOUN
aiua-4756	63	24	levels	level	NOUN
aiua-4756	63	25	are	be	AUX
aiua-4756	63	26	mildly	mildly	ADV
aiua-4756	63	27	high	high	ADJ
aiua-4756	63	28	(	(	PUNCT
aiua-4756	63	29	i.e.	i.e.	X
aiua-4756	63	30	4	4	NUM
aiua-4756	63	31	-	-	SYM
aiua-4756	63	32	10	10	NUM
aiua-4756	63	33	ng	ng	PROPN
aiua-4756	63	34	/	/	SYM
aiua-4756	63	35	ml	ml	PROPN
aiua-4756	63	36	)	)	PUNCT
aiua-4756	63	37	,	,	PUNCT
aiua-4756	63	38	in	in	ADP
aiua-4756	63	39	order	order	NOUN
aiua-4756	63	40	to	to	PART
aiua-4756	63	41	decide	decide	VERB
aiua-4756	63	42	whether	whether	SCONJ
aiua-4756	63	43	or	or	CCONJ
aiua-4756	63	44	not	not	PART
aiua-4756	63	45	to	to	PART
aiua-4756	63	46	carry	carry	VERB
aiua-4756	63	47	out	out	ADP
aiua-4756	63	48	the	the	DET
aiua-4756	63	49	biopsy	biopsy	NOUN
aiua-4756	63	50	on	on	ADP
aiua-4756	63	51	the	the	DET
aiua-4756	63	52	basis	basis	NOUN
aiua-4756	63	53	of	of	ADP
aiua-4756	63	54	the	the	DET
aiua-4756	63	55	subsequent	subsequent	ADJ
aiua-4756	63	56	re	re	VERB
aiua-4756	63	57	-	-	ADJ
aiua-4756	63	58	dosed	dose	VERB
aiua-4756	63	59	psa	psa	NOUN
aiua-4756	63	60	results	result	NOUN
aiua-4756	63	61	.	.	PUNCT
aiua-4756	64	1	bozeman	bozeman	NOUN
aiua-4756	64	2	et	et	PROPN
aiua-4756	64	3	al	al	PROPN
aiua-4756	64	4	.	.	PROPN
aiua-4756	64	5	reported	report	VERB
aiua-4756	64	6	that	that	SCONJ
aiua-4756	64	7	when	when	SCONJ
aiua-4756	64	8	serum	serum	PROPN
aiua-4756	64	9	psa	psa	PROPN
aiua-4756	64	10	had	have	AUX
aiua-4756	64	11	been	be	AUX
aiua-4756	64	12	normalized	normalize	VERB
aiua-4756	64	13	with	with	ADP
aiua-4756	64	14	treatment	treatment	NOUN
aiua-4756	64	15	there	there	PRON
aiua-4756	64	16	was	be	VERB
aiua-4756	64	17	no	no	ADV
aiua-4756	64	18	longer	long	ADV
aiua-4756	64	19	an	an	DET
aiua-4756	64	20	indication	indication	NOUN
aiua-4756	64	21	for	for	ADP
aiua-4756	64	22	transrectal	transrectal	ADJ
aiua-4756	64	23	ultrasound	ultrasound	NOUN
aiua-4756	64	24	-	-	PUNCT
aiua-4756	64	25	guided	guide	VERB
aiua-4756	64	26	biopsy	biopsy	NOUN
aiua-4756	64	27	in	in	ADP
aiua-4756	64	28	almost	almost	ADV
aiua-4756	64	29	cohort	cohort	NOUN
aiua-4756	64	30	1	1	NUM
aiua-4756	64	31	cohort	cohort	NOUN
aiua-4756	64	32	2	2	NUM
aiua-4756	64	33	49	49	NUM
aiua-4756	64	34	pts	pt	NOUN
aiua-4756	64	35	51	51	NUM
aiua-4756	64	36	pts	pt	NOUN
aiua-4756	64	37	antibiotics	antibiotic	NOUN
aiua-4756	64	38	no	no	DET
aiua-4756	64	39	antibiotics	antibiotic	NOUN
aiua-4756	64	40	significant	significant	ADJ
aiua-4756	64	41	decrease	decrease	NOUN
aiua-4756	64	42	of	of	ADP
aiua-4756	64	43	psa	psa	NOUN
aiua-4756	64	44	(	(	PUNCT
aiua-4756	64	45	>	>	X
aiua-4756	64	46	10	10	NUM
aiua-4756	64	47	%	%	NOUN
aiua-4756	64	48	)	)	PUNCT
aiua-4756	65	1	+	+	CCONJ
aiua-4756	65	2	29	29	NUM
aiua-4756	65	3	20	20	NUM
aiua-4756	65	4	+	+	NUM
aiua-4756	65	5	30	30	NUM
aiua-4756	65	6	-21	-21	NOUN
aiua-4756	65	7	prostate	prostate	NOUN
aiua-4756	65	8	cancer	cancer	NOUN
aiua-4756	65	9	6	6	NUM
aiua-4756	65	10	4	4	NUM
aiua-4756	65	11	7	7	NUM
aiua-4756	65	12	6	6	NUM
aiua-4756	65	13	chronic	chronic	ADJ
aiua-4756	65	14	inflammation	inflammation	NOUN
aiua-4756	65	15	5	5	NUM
aiua-4756	65	16	8	8	NUM
aiua-4756	65	17	5	5	NUM
aiua-4756	65	18	3	3	NUM
aiua-4756	65	19	bph	bph	NOUN
aiua-4756	65	20	only	only	ADV
aiua-4756	65	21	18	18	NUM
aiua-4756	65	22	8	8	NUM
aiua-4756	65	23	18	18	NUM
aiua-4756	65	24	12	12	NUM
aiua-4756	65	25	+	+	CCONJ
aiua-4756	65	26	affirmative	affirmative	ADJ
aiua-4756	65	27	/	/	SYM
aiua-4756	65	28	negative	negative	ADJ
aiua-4756	65	29	bph	bph	NOUN
aiua-4756	65	30	=	=	SYM
aiua-4756	65	31	prostate	prostate	NOUN
aiua-4756	65	32	benign	benign	ADJ
aiua-4756	65	33	hyperplasia	hyperplasia	NOUN
aiua-4756	65	34	psa	psa	NOUN
aiua-4756	65	35	=	=	SYM
aiua-4756	65	36	prostate	prostate	NOUN
aiua-4756	65	37	specific	specific	ADJ
aiua-4756	65	38	antigen	antigen	NOUN
aiua-4756	65	39	pts	pt	NOUN
aiua-4756	65	40	=	=	NOUN
aiua-4756	65	41	patients	patient	NOUN
aiua-4756	65	42	table	table	VERB
aiua-4756	65	43	1	1	NUM
aiua-4756	65	44	.	.	PUNCT
aiua-4756	66	1	fandella_stesura	fandella_stesura	ADJ
aiua-4756	66	2	seveso	seveso	NOUN
aiua-4756	66	3	08/10/14	08/10/14	PROPN
aiua-4756	66	4	12:12	12:12	NUM
aiua-4756	66	5	pagina	pagina	NOUN
aiua-4756	66	6	203	203	NUM
aiua-4756	66	7	archivio	archivio	NOUN
aiua-4756	66	8	italiano	italiano	X
aiua-4756	66	9	di	di	X
aiua-4756	66	10	urologia	urologia	PROPN
aiua-4756	66	11	e	e	PROPN
aiua-4756	66	12	andrologia	andrologia	NOUN
aiua-4756	66	13	2014	2014	NUM
aiua-4756	66	14	;	;	PUNCT
aiua-4756	66	15	86	86	NUM
aiua-4756	66	16	,	,	PUNCT
aiua-4756	66	17	3	3	NUM
aiua-4756	66	18	a.	a.	NOUN
aiua-4756	66	19	fandella	fandella	NOUN
aiua-4756	66	20	,	,	PUNCT
aiua-4756	66	21	s.	s.	PROPN
aiua-4756	66	22	benvenuto	benvenuto	PROPN
aiua-4756	66	23	,	,	PUNCT
aiua-4756	66	24	e.	e.	PROPN
aiua-4756	66	25	guidoni	guidoni	PROPN
aiua-4756	66	26	,	,	PUNCT
aiua-4756	66	27	m.	m.	NOUN
aiua-4756	66	28	giampaoli	giampaoli	PROPN
aiua-4756	66	29	,	,	PUNCT
aiua-4756	66	30	a.	a.	NOUN
aiua-4756	66	31	bertaccini	bertaccini	NOUN
aiua-4756	66	32	204	204	NUM
aiua-4756	66	33	half	half	NOUN
aiua-4756	66	34	of	of	ADP
aiua-4756	66	35	their	their	PRON
aiua-4756	66	36	95	95	NUM
aiua-4756	66	37	patients	patient	NOUN
aiua-4756	66	38	diagnosed	diagnose	VERB
aiua-4756	66	39	with	with	ADP
aiua-4756	66	40	elevated	elevated	ADJ
aiua-4756	66	41	psa	psa	NOUN
aiua-4756	66	42	and	and	CCONJ
aiua-4756	66	43	chronic	chronic	ADJ
aiua-4756	66	44	inflammation	inflammation	NOUN
aiua-4756	66	45	,	,	PUNCT
aiua-4756	66	46	suggesting	suggest	VERB
aiua-4756	66	47	that	that	SCONJ
aiua-4756	66	48	chronic	chronic	ADJ
aiua-4756	66	49	prostatitis	prostatitis	NOUN
aiua-4756	66	50	is	be	AUX
aiua-4756	66	51	an	an	DET
aiua-4756	66	52	important	important	ADJ
aiua-4756	66	53	cause	cause	NOUN
aiua-4756	66	54	of	of	ADP
aiua-4756	66	55	elevated	elevated	ADJ
aiua-4756	66	56	psa	psa	NOUN
aiua-4756	66	57	and	and	CCONJ
aiua-4756	66	58	that	that	SCONJ
aiua-4756	66	59	,	,	PUNCT
aiua-4756	66	60	when	when	SCONJ
aiua-4756	66	61	identified	identify	VERB
aiua-4756	66	62	,	,	PUNCT
aiua-4756	66	63	treatment	treatment	NOUN
aiua-4756	66	64	can	can	AUX
aiua-4756	66	65	decrease	decrease	VERB
aiua-4756	66	66	the	the	DET
aiua-4756	66	67	percent	percent	NOUN
aiua-4756	66	68	of	of	ADP
aiua-4756	66	69	negative	negative	ADJ
aiua-4756	66	70	biopsies	biopsy	NOUN
aiua-4756	66	71	(	(	PUNCT
aiua-4756	66	72	12	12	NUM
aiua-4756	66	73	)	)	PUNCT
aiua-4756	66	74	.	.	PUNCT
aiua-4756	67	1	a	a	DET
aiua-4756	67	2	recent	recent	ADJ
aiua-4756	67	3	editorial	editorial	NOUN
aiua-4756	67	4	by	by	ADP
aiua-4756	67	5	scardino	scardino	NOUN
aiua-4756	67	6	criticized	criticize	VERB
aiua-4756	67	7	the	the	DET
aiua-4756	67	8	unjustified	unjustified	ADJ
aiua-4756	67	9	use	use	NOUN
aiua-4756	67	10	of	of	ADP
aiua-4756	67	11	antibiotics	antibiotic	NOUN
aiua-4756	67	12	in	in	ADP
aiua-4756	67	13	a	a	DET
aiua-4756	67	14	group	group	NOUN
aiua-4756	67	15	of	of	ADP
aiua-4756	67	16	patients	patient	NOUN
aiua-4756	67	17	similar	similar	ADJ
aiua-4756	67	18	to	to	ADP
aiua-4756	67	19	ours	ours	PRON
aiua-4756	67	20	.	.	PUNCT
aiua-4756	68	1	he	he	PRON
aiua-4756	68	2	emphasized	emphasize	VERB
aiua-4756	68	3	the	the	DET
aiua-4756	68	4	various	various	ADJ
aiua-4756	68	5	inherent	inherent	ADJ
aiua-4756	68	6	disadvantages	disadvantage	NOUN
aiua-4756	68	7	associated	associate	VERB
aiua-4756	68	8	with	with	ADP
aiua-4756	68	9	this	this	DET
aiua-4756	68	10	approach	approach	NOUN
aiua-4756	68	11	,	,	PUNCT
aiua-4756	68	12	such	such	ADJ
aiua-4756	68	13	as	as	ADP
aiua-4756	68	14	costs	cost	NOUN
aiua-4756	68	15	,	,	PUNCT
aiua-4756	68	16	toxicity	toxicity	NOUN
aiua-4756	68	17	,	,	PUNCT
aiua-4756	68	18	and	and	CCONJ
aiua-4756	68	19	the	the	DET
aiua-4756	68	20	promotion	promotion	NOUN
aiua-4756	68	21	of	of	ADP
aiua-4756	68	22	resistant	resistant	ADJ
aiua-4756	68	23	bacterial	bacterial	ADJ
aiua-4756	68	24	species	specie	NOUN
aiua-4756	68	25	development	development	NOUN
aiua-4756	68	26	that	that	PRON
aiua-4756	68	27	would	would	AUX
aiua-4756	68	28	have	have	AUX
aiua-4756	68	29	exposed	expose	VERB
aiua-4756	68	30	the	the	DET
aiua-4756	68	31	biopsied	biopsied	ADJ
aiua-4756	68	32	patient	patient	NOUN
aiua-4756	68	33	to	to	ADP
aiua-4756	68	34	more	more	ADV
aiua-4756	68	35	resistant	resistant	ADJ
aiua-4756	68	36	and	and	CCONJ
aiua-4756	68	37	aggressive	aggressive	ADJ
aiua-4756	68	38	sepsis	sepsis	NOUN
aiua-4756	68	39	(	(	PUNCT
aiua-4756	68	40	8)	8)	NUM
aiua-4756	68	41	.	.	PUNCT
aiua-4756	69	1	significant	significant	ADJ
aiua-4756	69	2	fluctuations	fluctuation	NOUN
aiua-4756	69	3	in	in	ADP
aiua-4756	69	4	psa	psa	NOUN
aiua-4756	69	5	should	should	AUX
aiua-4756	69	6	raise	raise	VERB
aiua-4756	69	7	the	the	DET
aiua-4756	69	8	suspicion	suspicion	NOUN
aiua-4756	69	9	of	of	ADP
aiua-4756	69	10	inflammation	inflammation	NOUN
aiua-4756	69	11	or	or	CCONJ
aiua-4756	69	12	infection	infection	NOUN
aiua-4756	69	13	as	as	ADP
aiua-4756	69	14	an	an	DET
aiua-4756	69	15	aetiology	aetiology	NOUN
aiua-4756	69	16	,	,	PUNCT
aiua-4756	69	17	however	however	ADV
aiua-4756	69	18	in	in	ADP
aiua-4756	69	19	these	these	DET
aiua-4756	69	20	patients	patient	NOUN
aiua-4756	69	21	it	it	PRON
aiua-4756	69	22	remains	remain	VERB
aiua-4756	69	23	controversial	controversial	ADJ
aiua-4756	69	24	;	;	PUNCT
aiua-4756	69	25	empiric	empiric	ADJ
aiua-4756	69	26	antibiotics	antibiotic	NOUN
aiua-4756	69	27	therapy	therapy	NOUN
aiua-4756	69	28	prior	prior	ADV
aiua-4756	69	29	to	to	ADP
aiua-4756	69	30	a	a	DET
aiua-4756	69	31	prostate	prostate	NOUN
aiua-4756	69	32	biopsy	biopsy	NOUN
aiua-4756	69	33	in	in	ADP
aiua-4756	69	34	order	order	NOUN
aiua-4756	69	35	to	to	PART
aiua-4756	69	36	“	"	PUNCT
aiua-4756	69	37	normalize	normalize	VERB
aiua-4756	69	38	”	"	PUNCT
aiua-4756	69	39	the	the	DET
aiua-4756	69	40	psa	psa	NOUN
aiua-4756	69	41	value	value	NOUN
aiua-4756	69	42	remains	remain	VERB
aiua-4756	69	43	a	a	DET
aiua-4756	69	44	non	non	ADJ
aiua-4756	69	45	evidence	evidence	NOUN
aiua-4756	69	46	-	-	PUNCT
aiua-4756	69	47	based	base	VERB
aiua-4756	69	48	practice	practice	NOUN
aiua-4756	69	49	.	.	PUNCT
aiua-4756	70	1	those	those	PRON
aiua-4756	70	2	who	who	PRON
aiua-4756	70	3	underwent	undergo	VERB
aiua-4756	70	4	a	a	DET
aiua-4756	70	5	course	course	NOUN
aiua-4756	70	6	of	of	ADP
aiua-4756	70	7	fluoroquinolone	fluoroquinolone	NOUN
aiua-4756	70	8	antibiotics	antibiotic	NOUN
aiua-4756	70	9	treatment	treatment	NOUN
aiua-4756	70	10	should	should	AUX
aiua-4756	70	11	not	not	PART
aiua-4756	70	12	have	have	VERB
aiua-4756	70	13	a	a	DET
aiua-4756	70	14	prostate	prostate	NOUN
aiua-4756	70	15	biopsy	biopsy	NOUN
aiua-4756	70	16	within	within	ADP
aiua-4756	70	17	one	one	NUM
aiua-4756	70	18	month	month	NOUN
aiua-4756	70	19	from	from	ADP
aiua-4756	70	20	completing	complete	VERB
aiua-4756	70	21	the	the	DET
aiua-4756	70	22	therapy	therapy	NOUN
aiua-4756	70	23	to	to	PART
aiua-4756	70	24	allow	allow	VERB
aiua-4756	70	25	the	the	DET
aiua-4756	70	26	colonic	colonic	ADJ
aiua-4756	70	27	flora	flora	NOUN
aiua-4756	70	28	to	to	PART
aiua-4756	70	29	re	re	VERB
aiua-4756	70	30	-	-	VERB
aiua-4756	70	31	establish	establish	VERB
aiua-4756	70	32	itself	itself	PRON
aiua-4756	70	33	to	to	ADP
aiua-4756	70	34	a	a	DET
aiua-4756	70	35	normal	normal	ADJ
aiua-4756	70	36	state	state	NOUN
aiua-4756	70	37	.	.	PUNCT
aiua-4756	71	1	akduman	akduman	PROPN
aiua-4756	71	2	et	et	PROPN
aiua-4756	71	3	al	al	PROPN
aiua-4756	71	4	.	.	PROPN
aiua-4756	71	5	demonstrated	demonstrate	VERB
aiua-4756	71	6	that	that	SCONJ
aiua-4756	71	7	patients	patient	NOUN
aiua-4756	71	8	who	who	PRON
aiua-4756	71	9	received	receive	VERB
aiua-4756	71	10	3	3	NUM
aiua-4756	71	11	weeks	week	NOUN
aiua-4756	71	12	of	of	ADP
aiua-4756	71	13	fluoroquinolones	fluoroquinolone	NOUN
aiua-4756	71	14	before	before	SCONJ
aiua-4756	71	15	biopsy	biopsy	NOUN
aiua-4756	71	16	had	have	VERB
aiua-4756	71	17	a	a	DET
aiua-4756	71	18	significantly	significantly	ADV
aiua-4756	71	19	greater	great	ADJ
aiua-4756	71	20	incidence	incidence	NOUN
aiua-4756	71	21	of	of	ADP
aiua-4756	71	22	post	post	ADJ
aiua-4756	71	23	-	-	ADJ
aiua-4756	71	24	biopsy	biopsy	ADJ
aiua-4756	71	25	sepsis	sepsis	NOUN
aiua-4756	71	26	(	(	PUNCT
aiua-4756	71	27	5.4	5.4	NUM
aiua-4756	71	28	%	%	NOUN
aiua-4756	71	29	vs	vs	ADP
aiua-4756	71	30	1.7	1.7	NUM
aiua-4756	71	31	%	%	NOUN
aiua-4756	71	32	)	)	PUNCT
aiua-4756	71	33	and	and	CCONJ
aiua-4756	71	34	all	all	DET
aiua-4756	71	35	sepsis	sepsis	NOUN
aiua-4756	71	36	episodes	episode	NOUN
aiua-4756	71	37	were	be	AUX
aiua-4756	71	38	attributable	attributable	ADJ
aiua-4756	71	39	to	to	ADP
aiua-4756	71	40	quinolone	quinolone	ADJ
aiua-4756	71	41	resistant	resistant	ADJ
aiua-4756	71	42	bacteria	bacteria	NOUN
aiua-4756	71	43	(	(	PUNCT
aiua-4756	71	44	13	13	NUM
aiua-4756	71	45	)	)	PUNCT
aiua-4756	71	46	.	.	PUNCT
aiua-4756	72	1	other	other	ADJ
aiua-4756	72	2	studies	study	NOUN
aiua-4756	72	3	have	have	AUX
aiua-4756	72	4	similarly	similarly	ADV
aiua-4756	72	5	shown	show	VERB
aiua-4756	72	6	that	that	SCONJ
aiua-4756	72	7	previous	previous	ADJ
aiua-4756	72	8	therapy	therapy	NOUN
aiua-4756	72	9	with	with	ADP
aiua-4756	72	10	quinolones	quinolone	NOUN
aiua-4756	72	11	predisposes	predispose	NOUN
aiua-4756	72	12	to	to	ADP
aiua-4756	72	13	rectal	rectal	ADJ
aiua-4756	72	14	flora	flora	NOUN
aiua-4756	72	15	resistance	resistance	NOUN
aiua-4756	72	16	(	(	PUNCT
aiua-4756	72	17	14	14	NUM
aiua-4756	72	18	)	)	PUNCT
aiua-4756	72	19	.	.	PUNCT
aiua-4756	73	1	the	the	DET
aiua-4756	73	2	results	result	NOUN
aiua-4756	73	3	of	of	ADP
aiua-4756	73	4	this	this	DET
aiua-4756	73	5	study	study	NOUN
aiua-4756	73	6	seems	seem	VERB
aiua-4756	73	7	to	to	PART
aiua-4756	73	8	show	show	VERB
aiua-4756	73	9	no	no	DET
aiua-4756	73	10	advantages	advantage	NOUN
aiua-4756	73	11	due	due	ADJ
aiua-4756	73	12	to	to	ADP
aiua-4756	73	13	an	an	DET
aiua-4756	73	14	empiric	empiric	ADJ
aiua-4756	73	15	antibiotic	antibiotic	ADJ
aiua-4756	73	16	therapy	therapy	NOUN
aiua-4756	73	17	(	(	PUNCT
aiua-4756	73	18	full	full	ADJ
aiua-4756	73	19	dose	dose	NOUN
aiua-4756	73	20	floroquinolone	floroquinolone	NOUN
aiua-4756	73	21	for	for	ADP
aiua-4756	73	22	20	20	NUM
aiua-4756	73	23	days	day	NOUN
aiua-4756	73	24	,	,	PUNCT
aiua-4756	73	25	in	in	ADP
aiua-4756	73	26	this	this	DET
aiua-4756	73	27	specific	specific	ADJ
aiua-4756	73	28	case	case	NOUN
aiua-4756	73	29	)	)	PUNCT
aiua-4756	73	30	to	to	PART
aiua-4756	73	31	reduce	reduce	VERB
aiua-4756	73	32	psa	psa	NOUN
aiua-4756	73	33	values	value	NOUN
aiua-4756	73	34	and	and	CCONJ
aiua-4756	73	35	avoid	avoid	VERB
aiua-4756	73	36	unnecessary	unnecessary	ADJ
aiua-4756	73	37	biopsy	biopsy	NOUN
aiua-4756	73	38	in	in	ADP
aiua-4756	73	39	patients	patient	NOUN
aiua-4756	73	40	with	with	ADP
aiua-4756	73	41	psa	psa	NOUN
aiua-4756	73	42	levels	level	NOUN
aiua-4756	73	43	between	between	ADP
aiua-4756	73	44	4	4	NUM
aiua-4756	73	45	-	-	SYM
aiua-4756	73	46	10	10	NUM
aiua-4756	73	47	ng	ng	PROPN
aiua-4756	73	48	/	/	SYM
aiua-4756	73	49	ml	ml	NOUN
aiua-4756	73	50	and	and	CCONJ
aiua-4756	73	51	no	no	DET
aiua-4756	73	52	signs	sign	NOUN
aiua-4756	73	53	or	or	CCONJ
aiua-4756	73	54	symptoms	symptom	NOUN
aiua-4756	73	55	of	of	ADP
aiua-4756	73	56	infections	infection	NOUN
aiua-4756	73	57	.	.	PUNCT
aiua-4756	74	1	a	a	DET
aiua-4756	74	2	psa	psa	NOUN
aiua-4756	74	3	decrease	decrease	NOUN
aiua-4756	74	4	after	after	ADP
aiua-4756	74	5	antibiotic	antibiotic	ADJ
aiua-4756	74	6	therapy	therapy	NOUN
aiua-4756	74	7	does	do	AUX
aiua-4756	74	8	not	not	PART
aiua-4756	74	9	rule	rule	VERB
aiua-4756	74	10	out	out	ADP
aiua-4756	74	11	prostate	prostate	NOUN
aiua-4756	74	12	cancer	cancer	NOUN
aiua-4756	74	13	and	and	CCONJ
aiua-4756	74	14	at	at	ADP
aiua-4756	74	15	the	the	DET
aiua-4756	74	16	same	same	ADJ
aiua-4756	74	17	time	time	NOUN
aiua-4756	74	18	a	a	DET
aiua-4756	74	19	lack	lack	NOUN
aiua-4756	74	20	of	of	ADP
aiua-4756	74	21	decrease	decrease	NOUN
aiua-4756	74	22	does	do	AUX
aiua-4756	74	23	not	not	PART
aiua-4756	74	24	exclude	exclude	VERB
aiua-4756	74	25	it	it	PRON
aiua-4756	74	26	.	.	PUNCT
aiua-4756	75	1	thus	thus	ADV
aiua-4756	75	2	antibiotics	antibiotic	NOUN
aiua-4756	75	3	therapy	therapy	NOUN
aiua-4756	75	4	does	do	AUX
aiua-4756	75	5	not	not	PART
aiua-4756	75	6	seem	seem	VERB
aiua-4756	75	7	to	to	PART
aiua-4756	75	8	eliminate	eliminate	VERB
aiua-4756	75	9	unnecessary	unnecessary	ADJ
aiua-4756	75	10	prostate	prostate	NOUN
aiua-4756	75	11	biopsy	biopsy	NOUN
aiua-4756	75	12	.	.	PUNCT
aiua-4756	76	1	our	our	PRON
aiua-4756	76	2	trial	trial	NOUN
aiua-4756	76	3	does	do	AUX
aiua-4756	76	4	have	have	VERB
aiua-4756	76	5	some	some	DET
aiua-4756	76	6	limitations	limitation	NOUN
aiua-4756	76	7	:	:	PUNCT
aiua-4756	76	8	patients	patient	NOUN
aiua-4756	76	9	number	number	NOUN
aiua-4756	76	10	and	and	CCONJ
aiua-4756	76	11	retrospective	retrospective	ADJ
aiua-4756	76	12	design	design	NOUN
aiua-4756	76	13	.	.	PUNCT
aiua-4756	77	1	we	we	PRON
aiua-4756	77	2	had	have	VERB
aiua-4756	77	3	few	few	ADJ
aiua-4756	77	4	cases	case	NOUN
aiua-4756	77	5	with	with	ADP
aiua-4756	77	6	histological	histological	ADJ
aiua-4756	77	7	evidence	evidence	NOUN
aiua-4756	77	8	for	for	ADP
aiua-4756	77	9	chronic	chronic	ADJ
aiua-4756	77	10	prostatitis	prostatitis	NOUN
aiua-4756	77	11	in	in	ADP
aiua-4756	77	12	our	our	PRON
aiua-4756	77	13	study	study	NOUN
aiua-4756	77	14	.	.	PUNCT
aiua-4756	78	1	this	this	PRON
aiua-4756	78	2	might	might	AUX
aiua-4756	78	3	explain	explain	VERB
aiua-4756	78	4	why	why	SCONJ
aiua-4756	78	5	administration	administration	NOUN
aiua-4756	78	6	of	of	ADP
aiua-4756	78	7	antibacterial	antibacterial	ADJ
aiua-4756	78	8	therapy	therapy	NOUN
aiua-4756	78	9	was	be	AUX
aiua-4756	78	10	not	not	PART
aiua-4756	78	11	helpful	helpful	ADJ
aiua-4756	78	12	in	in	ADP
aiua-4756	78	13	our	our	PRON
aiua-4756	78	14	series	series	NOUN
aiua-4756	78	15	.	.	PUNCT
aiua-4756	79	1	we	we	PRON
aiua-4756	79	2	also	also	ADV
aiua-4756	79	3	studied	study	VERB
aiua-4756	79	4	only	only	ADV
aiua-4756	79	5	a	a	DET
aiua-4756	79	6	single	single	ADJ
aiua-4756	79	7	class	class	NOUN
aiua-4756	79	8	of	of	ADP
aiua-4756	79	9	antibiotic	antibiotic	NOUN
aiua-4756	79	10	for	for	ADP
aiua-4756	79	11	20	20	NUM
aiua-4756	79	12	days	day	NOUN
aiua-4756	79	13	,	,	PUNCT
aiua-4756	79	14	which	which	PRON
aiua-4756	79	15	we	we	PRON
aiua-4756	79	16	believed	believe	VERB
aiua-4756	79	17	to	to	PART
aiua-4756	79	18	be	be	AUX
aiua-4756	79	19	the	the	DET
aiua-4756	79	20	most	most	ADV
aiua-4756	79	21	commonly	commonly	ADV
aiua-4756	79	22	used	use	VERB
aiua-4756	79	23	in	in	ADP
aiua-4756	79	24	current	current	ADJ
aiua-4756	79	25	clinical	clinical	ADJ
aiua-4756	79	26	practice	practice	NOUN
aiua-4756	79	27	.	.	PUNCT
aiua-4756	80	1	it	it	PRON
aiua-4756	80	2	is	be	AUX
aiua-4756	80	3	possible	possible	ADJ
aiua-4756	80	4	that	that	SCONJ
aiua-4756	80	5	a	a	DET
aiua-4756	80	6	different	different	ADJ
aiua-4756	80	7	class	class	NOUN
aiua-4756	80	8	or	or	CCONJ
aiua-4756	80	9	length	length	NOUN
aiua-4756	80	10	of	of	ADP
aiua-4756	80	11	therapy	therapy	NOUN
aiua-4756	80	12	might	might	AUX
aiua-4756	80	13	alter	alter	VERB
aiua-4756	80	14	the	the	DET
aiua-4756	80	15	above	above	ADJ
aiua-4756	80	16	findings	finding	NOUN
aiua-4756	80	17	.	.	PUNCT
aiua-4756	81	1	it	it	PRON
aiua-4756	81	2	is	be	AUX
aiua-4756	81	3	possible	possible	ADJ
aiua-4756	81	4	that	that	SCONJ
aiua-4756	81	5	a	a	DET
aiua-4756	81	6	larger	large	ADJ
aiua-4756	81	7	prospective	prospective	ADJ
aiua-4756	81	8	trial	trial	NOUN
aiua-4756	81	9	might	might	AUX
aiua-4756	81	10	identify	identify	VERB
aiua-4756	81	11	a	a	DET
aiua-4756	81	12	clinical	clinical	ADJ
aiua-4756	81	13	benefit	benefit	NOUN
aiua-4756	81	14	for	for	ADP
aiua-4756	81	15	empiric	empiric	ADJ
aiua-4756	81	16	antibiotic	antibiotic	ADJ
aiua-4756	81	17	treatments	treatment	NOUN
aiua-4756	81	18	.	.	PUNCT
aiua-4756	82	1	conclusions	conclusion	NOUN
aiua-4756	82	2	it	it	PRON
aiua-4756	82	3	is	be	AUX
aiua-4756	82	4	of	of	ADP
aiua-4756	82	5	crucial	crucial	ADJ
aiua-4756	82	6	importance	importance	NOUN
aiua-4756	82	7	to	to	PART
aiua-4756	82	8	use	use	VERB
aiua-4756	82	9	properly	properly	ADV
aiua-4756	82	10	and	and	CCONJ
aiua-4756	82	11	responsibly	responsibly	ADV
aiua-4756	82	12	antibiotics	antibiotic	NOUN
aiua-4756	82	13	.	.	PUNCT
aiua-4756	83	1	in	in	ADP
aiua-4756	83	2	patients	patient	NOUN
aiua-4756	83	3	with	with	ADP
aiua-4756	83	4	an	an	DET
aiua-4756	83	5	increased	increase	VERB
aiua-4756	83	6	psa	psa	NOUN
aiua-4756	83	7	,	,	PUNCT
aiua-4756	83	8	antibiotics	antibiotic	NOUN
aiua-4756	83	9	are	be	AUX
aiua-4756	83	10	appropriate	appropriate	ADJ
aiua-4756	83	11	if	if	SCONJ
aiua-4756	83	12	there	there	PRON
aiua-4756	83	13	is	be	VERB
aiua-4756	83	14	any	any	DET
aiua-4756	83	15	clinical	clinical	ADJ
aiua-4756	83	16	suspicion	suspicion	NOUN
aiua-4756	83	17	or	or	CCONJ
aiua-4756	83	18	evidence	evidence	NOUN
aiua-4756	83	19	of	of	ADP
aiua-4756	83	20	urinary	urinary	ADJ
aiua-4756	83	21	infection	infection	NOUN
aiua-4756	83	22	.	.	PUNCT
aiua-4756	84	1	any	any	DET
aiua-4756	84	2	rise	rise	NOUN
aiua-4756	84	3	of	of	ADP
aiua-4756	84	4	psa	psa	NOUN
aiua-4756	84	5	should	should	AUX
aiua-4756	84	6	be	be	AUX
aiua-4756	84	7	an	an	DET
aiua-4756	84	8	indication	indication	NOUN
aiua-4756	84	9	to	to	PART
aiua-4756	84	10	repeat	repeat	VERB
aiua-4756	84	11	psa	psa	NOUN
aiua-4756	84	12	testing	testing	NOUN
aiua-4756	84	13	.	.	PUNCT
aiua-4756	85	1	at	at	ADP
aiua-4756	85	2	the	the	DET
aiua-4756	85	3	same	same	ADJ
aiua-4756	85	4	time	time	NOUN
aiua-4756	85	5	we	we	PRON
aiua-4756	85	6	advocate	advocate	VERB
aiua-4756	85	7	the	the	DET
aiua-4756	85	8	use	use	NOUN
aiua-4756	85	9	of	of	ADP
aiua-4756	85	10	antibiotic	antibiotic	ADJ
aiua-4756	85	11	therapies	therapy	NOUN
aiua-4756	85	12	only	only	ADV
aiua-4756	85	13	if	if	SCONJ
aiua-4756	85	14	a	a	DET
aiua-4756	85	15	bacterial	bacterial	ADJ
aiua-4756	85	16	cause	cause	NOUN
aiua-4756	85	17	has	have	AUX
aiua-4756	85	18	been	be	AUX
aiua-4756	85	19	identified	identify	VERB
aiua-4756	85	20	.	.	PUNCT
aiua-4756	86	1	empiric	empiric	ADJ
aiua-4756	86	2	use	use	NOUN
aiua-4756	86	3	does	do	AUX
aiua-4756	86	4	n’t	not	PART
aiua-4756	86	5	seem	seem	VERB
aiua-4756	86	6	to	to	PART
aiua-4756	86	7	be	be	AUX
aiua-4756	86	8	of	of	ADP
aiua-4756	86	9	clinical	clinical	ADJ
aiua-4756	86	10	benefit	benefit	NOUN
aiua-4756	86	11	in	in	ADP
aiua-4756	86	12	absence	absence	NOUN
aiua-4756	86	13	of	of	ADP
aiua-4756	86	14	a	a	DET
aiua-4756	86	15	clinical	clinical	ADJ
aiua-4756	86	16	or	or	CCONJ
aiua-4756	86	17	laboratory	laboratory	NOUN
aiua-4756	86	18	evidence	evidence	NOUN
aiua-4756	86	19	of	of	ADP
aiua-4756	86	20	infection	infection	NOUN
aiua-4756	86	21	and	and	CCONJ
aiua-4756	86	22	it	it	PRON
aiua-4756	86	23	might	might	AUX
aiua-4756	86	24	paradoxically	paradoxically	ADV
aiua-4756	86	25	be	be	AUX
aiua-4756	86	26	harmful	harmful	ADJ
aiua-4756	86	27	.	.	PUNCT
aiua-4756	87	1	repeating	repeat	VERB
aiua-4756	87	2	a	a	DET
aiua-4756	87	3	new	new	ADJ
aiua-4756	87	4	psa	psa	NOUN
aiua-4756	87	5	test	test	NOUN
aiua-4756	87	6	before	before	ADP
aiua-4756	87	7	scheduling	schedule	VERB
aiua-4756	87	8	a	a	DET
aiua-4756	87	9	biopsy	biopsy	NOUN
aiua-4756	87	10	remains	remain	VERB
aiua-4756	87	11	the	the	DET
aiua-4756	87	12	only	only	ADJ
aiua-4756	87	13	acceptable	acceptable	ADJ
aiua-4756	87	14	approach	approach	NOUN
aiua-4756	87	15	.	.	PUNCT
aiua-4756	88	1	references	reference	NOUN
aiua-4756	88	2	1	1	NUM
aiua-4756	88	3	.	.	PUNCT
aiua-4756	88	4	ornstein	ornstein	PROPN
aiua-4756	88	5	dk	dk	PROPN
aiua-4756	88	6	,	,	PUNCT
aiua-4756	88	7	smith	smith	PROPN
aiua-4756	88	8	ds	ds	PROPN
aiua-4756	88	9	,	,	PUNCT
aiua-4756	88	10	rao	rao	NOUN
aiua-4756	88	11	gs	gs	PROPN
aiua-4756	88	12	,	,	PUNCT
aiua-4756	88	13	et	et	PROPN
aiua-4756	88	14	al	al	PROPN
aiua-4756	88	15	.	.	PUNCT
aiua-4756	89	1	biological	biological	ADJ
aiua-4756	89	2	variation	variation	NOUN
aiua-4756	89	3	of	of	ADP
aiua-4756	89	4	total	total	ADJ
aiua-4756	89	5	,	,	PUNCT
aiua-4756	89	6	free	free	ADJ
aiua-4756	89	7	and	and	CCONJ
aiua-4756	89	8	percent	percent	NOUN
aiua-4756	89	9	free	free	ADJ
aiua-4756	89	10	serum	serum	NOUN
aiua-4756	89	11	prostate	prostate	NOUN
aiua-4756	89	12	specific	specific	ADJ
aiua-4756	89	13	antigen	antigen	ADJ
aiua-4756	89	14	levels	level	NOUN
aiua-4756	89	15	in	in	ADP
aiua-4756	89	16	screening	screen	VERB
aiua-4756	89	17	volunteers	volunteer	NOUN
aiua-4756	89	18	.	.	PUNCT
aiua-4756	90	1	j	j	PROPN
aiua-4756	90	2	urol	urol	PROPN
aiua-4756	90	3	.	.	PUNCT
aiua-4756	90	4	1997	1997	NUM
aiua-4756	90	5	;	;	PUNCT
aiua-4756	90	6	157:2179	157:2179	NUM
aiua-4756	90	7	-	-	SYM
aiua-4756	90	8	82	82	NUM
aiua-4756	90	9	.	.	NOUN
aiua-4756	90	10	2	2	X
aiua-4756	90	11	.	.	X
aiua-4756	90	12	lorente	lorente	PROPN
aiua-4756	90	13	ja	ja	PROPN
aiua-4756	90	14	,	,	PUNCT
aiua-4756	90	15	arango	arango	PROPN
aiua-4756	90	16	o	o	NOUN
aiua-4756	90	17	,	,	PUNCT
aiua-4756	90	18	bielsa	bielsa	VERB
aiua-4756	90	19	o	o	PROPN
aiua-4756	90	20	,	,	PUNCT
aiua-4756	90	21	et	et	PROPN
aiua-4756	90	22	al	al	PROPN
aiua-4756	90	23	.	.	PROPN
aiua-4756	90	24	effect	effect	NOUN
aiua-4756	90	25	of	of	ADP
aiua-4756	90	26	antibiotic	antibiotic	ADJ
aiua-4756	90	27	treatment	treatment	NOUN
aiua-4756	90	28	on	on	ADP
aiua-4756	90	29	serum	serum	NOUN
aiua-4756	90	30	psa	psa	NOUN
aiua-4756	90	31	and	and	CCONJ
aiua-4756	90	32	percent	percent	NOUN
aiua-4756	90	33	free	free	ADJ
aiua-4756	90	34	psa	psa	NOUN
aiua-4756	90	35	levels	level	NOUN
aiua-4756	90	36	in	in	ADP
aiua-4756	90	37	patients	patient	NOUN
aiua-4756	90	38	with	with	ADP
aiua-4756	90	39	biochemical	biochemical	ADJ
aiua-4756	90	40	criteria	criterion	NOUN
aiua-4756	90	41	for	for	ADP
aiua-4756	90	42	prostate	prostate	NOUN
aiua-4756	90	43	biopsy	biopsy	NOUN
aiua-4756	90	44	and	and	CCONJ
aiua-4756	90	45	previous	previous	ADJ
aiua-4756	90	46	lower	low	ADJ
aiua-4756	90	47	urinary	urinary	ADJ
aiua-4756	90	48	tract	tract	NOUN
aiua-4756	90	49	infections	infection	NOUN
aiua-4756	90	50	.	.	PUNCT
aiua-4756	91	1	int	int	NOUN
aiua-4756	91	2	j	j	PROPN
aiua-4756	91	3	biol	biol	PROPN
aiua-4756	91	4	markers	marker	NOUN
aiua-4756	91	5	.	.	PUNCT
aiua-4756	92	1	2002	2002	NUM
aiua-4756	92	2	;	;	PUNCT
aiua-4756	92	3	17:84	17:84	NUM
aiua-4756	92	4	-	-	SYM
aiua-4756	92	5	9	9	NUM
aiua-4756	92	6	.	.	NOUN
aiua-4756	92	7	3	3	NUM
aiua-4756	92	8	.	.	X
aiua-4756	92	9	ozen	ozen	PROPN
aiua-4756	92	10	h	h	NOUN
aiua-4756	92	11	,	,	PUNCT
aiua-4756	92	12	aygün	aygün	NOUN
aiua-4756	92	13	c	c	NOUN
aiua-4756	92	14	,	,	PUNCT
aiua-4756	92	15	ergen	ergen	PROPN
aiua-4756	92	16	a	a	X
aiua-4756	92	17	,	,	PUNCT
aiua-4756	92	18	et	et	PROPN
aiua-4756	92	19	al	al	PROPN
aiua-4756	92	20	.	.	PROPN
aiua-4756	92	21	combined	combine	VERB
aiua-4756	92	22	use	use	NOUN
aiua-4756	92	23	of	of	ADP
aiua-4756	92	24	prostate	prostate	NOUN
aiua-4756	92	25	-	-	PUNCT
aiua-4756	92	26	specific	specific	ADJ
aiua-4756	92	27	antigen	antigen	ADJ
aiua-4756	92	28	derivatives	derivative	NOUN
aiua-4756	92	29	decreases	decrease	VERB
aiua-4756	92	30	the	the	DET
aiua-4756	92	31	number	number	NOUN
aiua-4756	92	32	of	of	ADP
aiua-4756	92	33	unnecessary	unnecessary	ADJ
aiua-4756	92	34	biopsies	biopsy	NOUN
aiua-4756	92	35	to	to	PART
aiua-4756	92	36	detect	detect	VERB
aiua-4756	92	37	prostate	prostate	NOUN
aiua-4756	92	38	cancer	cancer	NOUN
aiua-4756	92	39	.	.	PUNCT
aiua-4756	93	1	am	be	AUX
aiua-4756	93	2	j	j	PROPN
aiua-4756	93	3	clin	clin	PROPN
aiua-4756	93	4	oncol	oncol	PROPN
aiua-4756	93	5	.	.	PUNCT
aiua-4756	94	1	2001	2001	NUM
aiua-4756	94	2	;	;	PUNCT
aiua-4756	94	3	24:610	24:610	NUM
aiua-4756	94	4	-	-	SYM
aiua-4756	94	5	3	3	NUM
aiua-4756	94	6	.	.	NOUN
aiua-4756	94	7	4	4	NUM
aiua-4756	94	8	.	.	X
aiua-4756	95	1	kaygisiz	kaygisiz	PROPN
aiua-4756	95	2	o	o	PROPN
aiua-4756	95	3	,	,	PUNCT
aiua-4756	95	4	ugurlu	ugurlu	ADJ
aiua-4756	95	5	o	o	NOUN
aiua-4756	95	6	,	,	PUNCT
aiua-4756	95	7	kosan	kosan	PROPN
aiua-4756	95	8	m	m	PROPN
aiua-4756	95	9	,	,	PUNCT
aiua-4756	95	10	et	et	PROPN
aiua-4756	95	11	al	al	PROPN
aiua-4756	95	12	.	.	PUNCT
aiua-4756	95	13	effects	effect	NOUN
aiua-4756	95	14	of	of	ADP
aiua-4756	95	15	antibacterial	antibacterial	ADJ
aiua-4756	95	16	therapy	therapy	NOUN
aiua-4756	95	17	on	on	ADP
aiua-4756	95	18	psa	psa	NOUN
aiua-4756	95	19	change	change	NOUN
aiua-4756	95	20	in	in	ADP
aiua-4756	95	21	the	the	DET
aiua-4756	95	22	presence	presence	NOUN
aiua-4756	95	23	and	and	CCONJ
aiua-4756	95	24	absence	absence	NOUN
aiua-4756	95	25	of	of	ADP
aiua-4756	95	26	prostatic	prostatic	ADJ
aiua-4756	95	27	inflammation	inflammation	NOUN
aiua-4756	95	28	in	in	ADP
aiua-4756	95	29	patients	patient	NOUN
aiua-4756	95	30	with	with	ADP
aiua-4756	95	31	psa	psa	NOUN
aiua-4756	95	32	levels	level	NOUN
aiua-4756	95	33	between	between	ADP
aiua-4756	95	34	4	4	NUM
aiua-4756	95	35	and	and	CCONJ
aiua-4756	95	36	10	10	NUM
aiua-4756	95	37	ng	ng	PROPN
aiua-4756	95	38	/	/	SYM
aiua-4756	95	39	ml	ml	PROPN
aiua-4756	95	40	.	.	PUNCT
aiua-4756	96	1	prostate	prostate	NOUN
aiua-4756	96	2	cancer	cancer	NOUN
aiua-4756	96	3	prostatic	prostatic	ADJ
aiua-4756	96	4	dis	dis	PROPN
aiua-4756	96	5	.	.	PUNCT
aiua-4756	97	1	2006	2006	NUM
aiua-4756	97	2	;	;	PUNCT
aiua-4756	97	3	9:235	9:235	NUM
aiua-4756	97	4	-	-	SYM
aiua-4756	97	5	8	8	NUM
aiua-4756	97	6	.	.	NOUN
aiua-4756	97	7	5	5	NUM
aiua-4756	97	8	.	.	PUNCT
aiua-4756	97	9	baltaci	baltaci	NOUN
aiua-4756	97	10	s	s	NOUN
aiua-4756	97	11	,	,	PUNCT
aiua-4756	97	12	suer	suer	PROPN
aiua-4756	97	13	e	e	PROPN
aiua-4756	97	14	,	,	PUNCT
aiua-4756	97	15	haliloglu	haliloglu	PROPN
aiua-4756	97	16	ah	ah	INTJ
aiua-4756	97	17	,	,	PUNCT
aiua-4756	97	18	et	et	PROPN
aiua-4756	97	19	al	al	PROPN
aiua-4756	97	20	.	.	PROPN
aiua-4756	97	21	effectiveness	effectiveness	NOUN
aiua-4756	97	22	of	of	ADP
aiua-4756	97	23	antibiotics	antibiotic	NOUN
aiua-4756	97	24	given	give	VERB
aiua-4756	97	25	to	to	ADP
aiua-4756	97	26	asymptomatic	asymptomatic	ADJ
aiua-4756	97	27	men	man	NOUN
aiua-4756	97	28	for	for	ADP
aiua-4756	97	29	an	an	DET
aiua-4756	97	30	increased	increase	VERB
aiua-4756	97	31	prostate	prostate	NOUN
aiua-4756	97	32	specific	specific	ADJ
aiua-4756	97	33	antigen	antigen	NOUN
aiua-4756	97	34	.	.	PUNCT
aiua-4756	98	1	j	j	PROPN
aiua-4756	98	2	urol	urol	PROPN
aiua-4756	98	3	.	.	PUNCT
aiua-4756	98	4	2009	2009	NUM
aiua-4756	98	5	;	;	PUNCT
aiua-4756	98	6	181:128	181:128	NOUN
aiua-4756	98	7	.	.	PUNCT
aiua-4756	99	1	6	6	NUM
aiua-4756	99	2	.	.	X
aiua-4756	99	3	serretta	serretta	PROPN
aiua-4756	99	4	v	v	PROPN
aiua-4756	99	5	,	,	PUNCT
aiua-4756	99	6	catanese	catanese	NOUN
aiua-4756	99	7	a	a	PROPN
aiua-4756	99	8	,	,	PUNCT
aiua-4756	99	9	daricello	daricello	VERB
aiua-4756	99	10	g	g	PROPN
aiua-4756	99	11	,	,	PUNCT
aiua-4756	99	12	et	et	PROPN
aiua-4756	100	1	al	al	PROPN
aiua-4756	100	2	.	.	PROPN
aiua-4756	100	3	psa	psa	PROPN
aiua-4756	100	4	reduction	reduction	NOUN
aiua-4756	100	5	(	(	PUNCT
aiua-4756	100	6	after	after	ADP
aiua-4756	100	7	antibiotics	antibiotic	NOUN
aiua-4756	100	8	)	)	PUNCT
aiua-4756	100	9	permits	permit	VERB
aiua-4756	100	10	to	to	PART
aiua-4756	100	11	avoid	avoid	VERB
aiua-4756	100	12	or	or	CCONJ
aiua-4756	100	13	postpone	postpone	VERB
aiua-4756	100	14	prostate	prostate	NOUN
aiua-4756	100	15	biopsy	biopsy	NOUN
aiua-4756	100	16	in	in	ADP
aiua-4756	100	17	selected	select	VERB
aiua-4756	100	18	patients	patient	NOUN
aiua-4756	100	19	.	.	PUNCT
aiua-4756	101	1	prostate	prostate	NOUN
aiua-4756	101	2	cancer	cancer	NOUN
aiua-4756	101	3	prostatic	prostatic	ADJ
aiua-4756	101	4	dis	dis	PROPN
aiua-4756	101	5	.	.	PUNCT
aiua-4756	101	6	2008	2008	NUM
aiua-4756	101	7	;	;	PUNCT
aiua-4756	101	8	11:1485	11:1485	NUM
aiua-4756	101	9	.	.	PROPN
aiua-4756	101	10	7	7	NUM
aiua-4756	101	11	.	.	X
aiua-4756	101	12	erol	erol	PROPN
aiua-4756	101	13	h	h	PROPN
aiua-4756	101	14	,	,	PUNCT
aiua-4756	101	15	beder	beder	NOUN
aiua-4756	101	16	n	n	CCONJ
aiua-4756	101	17	,	,	PUNCT
aiua-4756	101	18	caliskan	caliskan	PROPN
aiua-4756	101	19	t	t	PROPN
aiua-4756	101	20	,	,	PUNCT
aiua-4756	101	21	et	et	PROPN
aiua-4756	101	22	al	al	PROPN
aiua-4756	101	23	.	.	PUNCT
aiua-4756	102	1	can	can	AUX
aiua-4756	102	2	the	the	DET
aiua-4756	102	3	effect	effect	NOUN
aiua-4756	102	4	of	of	ADP
aiua-4756	102	5	antibiotherapy	antibiotherapy	NOUN
aiua-4756	102	6	and	and	CCONJ
aiua-4756	102	7	anti	anti	ADJ
aiua-4756	102	8	-	-	ADJ
aiua-4756	102	9	inflammatory	inflammatory	ADJ
aiua-4756	102	10	therapy	therapy	NOUN
aiua-4756	102	11	on	on	ADP
aiua-4756	102	12	serum	serum	NOUN
aiua-4756	102	13	psa	psa	NOUN
aiua-4756	102	14	levels	level	NOUN
aiua-4756	102	15	discriminate	discriminate	VERB
aiua-4756	102	16	between	between	ADP
aiua-4756	102	17	benign	benign	ADJ
aiua-4756	102	18	and	and	CCONJ
aiua-4756	102	19	malign	malign	ADJ
aiua-4756	102	20	prostatic	prostatic	ADJ
aiua-4756	102	21	pathologies	pathology	NOUN
aiua-4756	102	22	?	?	PUNCT
aiua-4756	103	1	urol	urol	PROPN
aiua-4756	103	2	int	int	PROPN
aiua-4756	103	3	.	.	PUNCT
aiua-4756	104	1	2006	2006	NUM
aiua-4756	104	2	;	;	PUNCT
aiua-4756	104	3	76:20	76:20	NUM
aiua-4756	104	4	-	-	SYM
aiua-4756	104	5	6	6	NUM
aiua-4756	104	6	.	.	NOUN
aiua-4756	104	7	8	8	NUM
aiua-4756	104	8	.	.	PUNCT
aiua-4756	104	9	scardino	scardino	PROPN
aiua-4756	104	10	pt	pt	PROPN
aiua-4756	104	11	.	.	PUNCT
aiua-4756	105	1	the	the	DET
aiua-4756	105	2	responsible	responsible	ADJ
aiua-4756	105	3	use	use	NOUN
aiua-4756	105	4	of	of	ADP
aiua-4756	105	5	antibiotics	antibiotic	NOUN
aiua-4756	105	6	for	for	ADP
aiua-4756	105	7	an	an	DET
aiua-4756	105	8	elevated	elevated	ADJ
aiua-4756	105	9	psa	psa	NOUN
aiua-4756	105	10	level	level	NOUN
aiua-4756	105	11	.	.	PUNCT
aiua-4756	106	1	nat	nat	PROPN
aiua-4756	106	2	clin	clin	PROPN
aiua-4756	106	3	pract	pract	PROPN
aiua-4756	106	4	urol	urol	PROPN
aiua-4756	106	5	.	.	PUNCT
aiua-4756	106	6	2007	2007	NUM
aiua-4756	106	7	;	;	PUNCT
aiua-4756	106	8	4:1	4:1	NUM
aiua-4756	106	9	.	.	NOUN
aiua-4756	107	1	9	9	X
aiua-4756	107	2	.	.	X
aiua-4756	107	3	presti	presti	PROPN
aiua-4756	107	4	jc	jc	PROPN
aiua-4756	107	5	jr	jr	PROPN
aiua-4756	107	6	;	;	PUNCT
aiua-4756	107	7	prostate	prostate	NOUN
aiua-4756	107	8	biopsy	biopsy	NOUN
aiua-4756	107	9	strategies	strategy	NOUN
aiua-4756	107	10	.	.	PUNCT
aiua-4756	108	1	nat	nat	PROPN
aiua-4756	108	2	clin	clin	PROPN
aiua-4756	108	3	pract	pract	PROPN
aiua-4756	108	4	urol	urol	PROPN
aiua-4756	108	5	.	.	PUNCT
aiua-4756	108	6	2007	2007	NUM
aiua-4756	108	7	;	;	PUNCT
aiua-4756	108	8	4:505	4:505	NUM
aiua-4756	108	9	-	-	SYM
aiua-4756	108	10	11	11	NUM
aiua-4756	108	11	.	.	PUNCT
aiua-4756	109	1	10	10	NUM
aiua-4756	109	2	.	.	X
aiua-4756	109	3	schatteman	schatteman	NOUN
aiua-4756	109	4	ph	ph	PROPN
aiua-4756	109	5	,	,	PUNCT
aiua-4756	109	6	hoekx	hoekx	PROPN
aiua-4756	109	7	l	l	PROPN
aiua-4756	109	8	,	,	PUNCT
aiua-4756	109	9	wyndaele	wyndaele	PROPN
aiua-4756	109	10	jj	jj	PROPN
aiua-4756	109	11	,	,	PUNCT
aiua-4756	109	12	et	et	PROPN
aiua-4756	109	13	al	al	PROPN
aiua-4756	109	14	.	.	PROPN
aiua-4756	110	1	inflammation	inflammation	NOUN
aiua-4756	110	2	in	in	ADP
aiua-4756	110	3	prostate	prostate	NOUN
aiua-4756	110	4	biopsies	biopsy	NOUN
aiua-4756	110	5	of	of	ADP
aiua-4756	110	6	men	man	NOUN
aiua-4756	110	7	without	without	ADP
aiua-4756	110	8	prostatic	prostatic	ADJ
aiua-4756	110	9	malignancy	malignancy	NOUN
aiua-4756	110	10	or	or	CCONJ
aiua-4756	110	11	clinical	clinical	ADJ
aiua-4756	110	12	prostatitis	prostatitis	NOUN
aiua-4756	110	13	:	:	PUNCT
aiua-4756	110	14	correlation	correlation	NOUN
aiua-4756	110	15	with	with	ADP
aiua-4756	110	16	total	total	ADJ
aiua-4756	110	17	serum	serum	NOUN
aiua-4756	110	18	psa	psa	NOUN
aiua-4756	110	19	and	and	CCONJ
aiua-4756	110	20	psa	psa	VERB
aiua-4756	110	21	density	density	NOUN
aiua-4756	110	22	.	.	PUNCT
aiua-4756	111	1	eur	eur	PROPN
aiua-4756	111	2	urol	urol	PROPN
aiua-4756	111	3	.	.	PUNCT
aiua-4756	111	4	2000	2000	NUM
aiua-4756	111	5	;	;	PUNCT
aiua-4756	111	6	37:404	37:404	NUM
aiua-4756	111	7	-	-	SYM
aiua-4756	111	8	12	12	NUM
aiua-4756	111	9	.	.	PUNCT
aiua-4756	112	1	11	11	NUM
aiua-4756	112	2	.	.	PUNCT
aiua-4756	113	1	habermacher	habermacher	PROPN
aiua-4756	113	2	gm	gm	PROPN
aiua-4756	113	3	,	,	PUNCT
aiua-4756	113	4	chason	chason	PROPN
aiua-4756	113	5	jt	jt	PROPN
aiua-4756	113	6	,	,	PUNCT
aiua-4756	113	7	schaeffer	schaeffer	PROPN
aiua-4756	113	8	aj	aj	PROPN
aiua-4756	113	9	.	.	PUNCT
aiua-4756	113	10	prostatitis	prostatitis	NOUN
aiua-4756	113	11	/	/	SYM
aiua-4756	113	12	chronic	chronic	ADJ
aiua-4756	113	13	pelvic	pelvic	ADJ
aiua-4756	113	14	pain	pain	NOUN
aiua-4756	113	15	syndrome	syndrome	NOUN
aiua-4756	113	16	.	.	PUNCT
aiua-4756	114	1	ann	ann	PROPN
aiua-4756	114	2	rev	rev	PROPN
aiua-4756	114	3	med	med	PROPN
aiua-4756	114	4	.	.	PUNCT
aiua-4756	114	5	2006	2006	NUM
aiua-4756	114	6	;	;	PUNCT
aiua-4756	114	7	57:195	57:195	NUM
aiua-4756	114	8	-	-	SYM
aiua-4756	114	9	206	206	NUM
aiua-4756	114	10	.	.	PUNCT
aiua-4756	115	1	12	12	NUM
aiua-4756	115	2	.	.	PUNCT
aiua-4756	116	1	bozeman	bozeman	PROPN
aiua-4756	116	2	cb	cb	PROPN
aiua-4756	116	3	,	,	PUNCT
aiua-4756	116	4	carver	carver	NOUN
aiua-4756	116	5	bs	bs	PROPN
aiua-4756	116	6	,	,	PUNCT
aiua-4756	116	7	eastham	eastham	PROPN
aiua-4756	116	8	ja	ja	PROPN
aiua-4756	116	9	,	,	PUNCT
aiua-4756	116	10	venable	venable	PROPN
aiua-4756	116	11	dd	dd	PROPN
aiua-4756	116	12	.	.	PUNCT
aiua-4756	116	13	treatment	treatment	NOUN
aiua-4756	116	14	of	of	ADP
aiua-4756	116	15	chronic	chronic	ADJ
aiua-4756	116	16	prostatitis	prostatitis	NOUN
aiua-4756	116	17	lowers	lower	VERB
aiua-4756	116	18	serum	serum	NOUN
aiua-4756	116	19	prostate	prostate	NOUN
aiua-4756	116	20	specific	specific	ADJ
aiua-4756	116	21	antigen	antigen	NOUN
aiua-4756	116	22	.	.	PUNCT
aiua-4756	117	1	j	j	PROPN
aiua-4756	117	2	urol	urol	PROPN
aiua-4756	117	3	.	.	PUNCT
aiua-4756	117	4	2002	2002	NUM
aiua-4756	117	5	;	;	PUNCT
aiua-4756	117	6	167:1723	167:1723	NUM
aiua-4756	117	7	-	-	SYM
aiua-4756	117	8	6	6	NUM
aiua-4756	117	9	.	.	NOUN
aiua-4756	117	10	13	13	NUM
aiua-4756	117	11	.	.	PUNCT
aiua-4756	118	1	akduman	akduman	PROPN
aiua-4756	118	2	b	b	PROPN
aiua-4756	118	3	,	,	PUNCT
aiua-4756	118	4	akduman	akduman	NOUN
aiua-4756	118	5	d	d	PROPN
aiua-4756	118	6	,	,	PUNCT
aiua-4756	118	7	tokgoz	tokgoz	PROPN
aiua-4756	118	8	h	h	NOUN
aiua-4756	118	9	,	,	PUNCT
aiua-4756	118	10	et	et	PROPN
aiua-4756	118	11	al	al	PROPN
aiua-4756	118	12	.	.	PUNCT
aiua-4756	119	1	long	long	ADJ
aiua-4756	119	2	-	-	PUNCT
aiua-4756	119	3	term	term	NOUN
aiua-4756	119	4	fluoroquinolone	fluoroquinolone	NOUN
aiua-4756	119	5	use	use	NOUN
aiua-4756	119	6	before	before	SCONJ
aiua-4756	119	7	the	the	DET
aiua-4756	119	8	prostate	prostate	NOUN
aiua-4756	119	9	biopsy	biopsy	NOUN
aiua-4756	119	10	may	may	AUX
aiua-4756	119	11	increase	increase	VERB
aiua-4756	119	12	the	the	DET
aiua-4756	119	13	risk	risk	NOUN
aiua-4756	119	14	of	of	ADP
aiua-4756	119	15	sepsis	sepsis	NOUN
aiua-4756	119	16	caused	cause	VERB
aiua-4756	119	17	by	by	ADP
aiua-4756	119	18	resistant	resistant	ADJ
aiua-4756	119	19	microorganisms	microorganism	NOUN
aiua-4756	119	20	.	.	PUNCT
aiua-4756	120	1	urology	urology	NOUN
aiua-4756	120	2	2011	2011	NUM
aiua-4756	120	3	;	;	PUNCT
aiua-4756	120	4	78:250	78:250	NUM
aiua-4756	120	5	.	.	PUNCT
aiua-4756	121	1	14	14	NUM
aiua-4756	121	2	.	.	PUNCT
aiua-4756	122	1	owens	owens	PROPN
aiua-4756	122	2	rc	rc	PROPN
aiua-4756	122	3	jr	jr	PROPN
aiua-4756	122	4	.	.	PROPN
aiua-4756	122	5	,	,	PUNCT
aiua-4756	122	6	ambrose	ambrose	PROPN
aiua-4756	122	7	pg	pg	PROPN
aiua-4756	122	8	.	.	PUNCT
aiua-4756	123	1	antimicrobial	antimicrobial	ADJ
aiua-4756	123	2	safety	safety	NOUN
aiua-4756	123	3	:	:	PUNCT
aiua-4756	123	4	focus	focus	VERB
aiua-4756	123	5	on	on	ADP
aiua-4756	123	6	fluoroquinolones	fluoroquinolone	NOUN
aiua-4756	123	7	.	.	PUNCT
aiua-4756	124	1	clin	clin	PROPN
aiua-4756	124	2	infect	infect	PROPN
aiua-4756	124	3	dis	dis	PROPN
aiua-4756	124	4	.	.	PUNCT
aiua-4756	125	1	2005	2005	NUM
aiua-4756	125	2	(	(	PUNCT
aiua-4756	125	3	suppl	suppl	PROPN
aiua-4756	125	4	.	.	PUNCT
aiua-4756	125	5	)	)	PUNCT
aiua-4756	125	6	;	;	PUNCT
aiua-4756	126	1	41	41	NUM
aiua-4756	126	2	:	:	PUNCT
aiua-4756	126	3	s144	s144	PROPN
aiua-4756	126	4	.	.	PUNCT
aiua-4756	126	5	correspondence	correspondence	NOUN
aiua-4756	126	6	andrea	andrea	PROPN
aiua-4756	126	7	fandella	fandella	PROPN
aiua-4756	126	8	,	,	PUNCT
aiua-4756	126	9	md	md	PROPN
aiua-4756	126	10	afandella@libero.it	afandella@libero.it	PROPN
aiua-4756	126	11	sara	sara	PROPN
aiua-4756	126	12	benvenuto	benvenuto	PROPN
aiua-4756	126	13	,	,	PUNCT
aiua-4756	126	14	md	md	PROPN
aiua-4756	126	15	elisa	elisa	PROPN
aiua-4756	126	16	guidoni	guidoni	PROPN
aiua-4756	126	17	,	,	PUNCT
aiua-4756	126	18	md	md	PROPN
aiua-4756	126	19	casa	casa	PROPN
aiua-4756	126	20	di	di	PROPN
aiua-4756	126	21	cura	cura	PROPN
aiua-4756	126	22	giovanni	giovanni	PROPN
aiua-4756	126	23	xxiii	xxiii	PROPN
aiua-4756	126	24	monastier	monastier	PROPN
aiua-4756	126	25	,	,	PUNCT
aiua-4756	126	26	treviso	treviso	PROPN
aiua-4756	126	27	,	,	PUNCT
aiua-4756	126	28	italy	italy	PROPN
aiua-4756	126	29	marco	marco	PROPN
aiua-4756	126	30	giampaoli	giampaoli	PROPN
aiua-4756	126	31	,	,	PUNCT
aiua-4756	126	32	md	md	PROPN
aiua-4756	126	33	giampaoli.marco85@gmail.com	giampaoli.marco85@gmail.com	PROPN
aiua-4756	126	34	alessandro	alessandro	PROPN
aiua-4756	126	35	bertaccini	bertaccini	PROPN
aiua-4756	126	36	,	,	PUNCT
aiua-4756	126	37	md	md	PROPN
aiua-4756	126	38	(	(	PUNCT
aiua-4756	126	39	corresponding	correspond	VERB
aiua-4756	126	40	author	author	NOUN
aiua-4756	126	41	)	)	PUNCT
aiua-4756	126	42	alessandro.bertaccini@gmail.com	alessandro.bertaccini@gmail.com	PROPN
aiua-4756	126	43	clinica	clinica	PROPN
aiua-4756	126	44	urologica	urologica	PROPN
aiua-4756	126	45	,	,	PUNCT
aiua-4756	126	46	alma	alma	NOUN
aiua-4756	126	47	mater	mater	PROPN
aiua-4756	126	48	studiorum	studiorum	PROPN
aiua-4756	126	49	,	,	PUNCT
aiua-4756	126	50	università	università	PROPN
aiua-4756	126	51	di	di	PROPN
aiua-4756	126	52	bologna	bologna	PROPN
aiua-4756	126	53	ospedale	ospedale	PROPN
aiua-4756	126	54	sant’orsola	sant’orsola	PROPN
aiua-4756	126	55	-	-	PUNCT
aiua-4756	126	56	malpighi	malpighi	PROPN
aiua-4756	126	57	,	,	PUNCT
aiua-4756	126	58	bologna	bologna	PROPN
aiua-4756	126	59	,	,	PUNCT
aiua-4756	126	60	italy	italy	PROPN
aiua-4756	126	61	fandella_stesura	fandella_stesura	NOUN
aiua-4756	126	62	seveso	seveso	VERB
aiua-4756	126	63	08/10/14	08/10/14	PROPN
aiua-4756	126	64	12:12	12:12	NUM
aiua-4756	126	65	pagina	pagina	NOUN
aiua-4756	126	66	204	204	NUM